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1.0 INTRODUCTION 
Trichomonas vaginalis is a protozoan parasite and etiologic agent for Trichomoniasis, a sexually 
transmitted disease (STD) (40). Trichomoniasis is a common non-viral sexually transmitted 
disease (114). The global incidence of trichomoniasis is 174 million annually (114). In South and 
South East Asia, 76.5 million new cases are reported annually (114). Symptomatic 
trichomoniasis is more common in women than in men. Trichomoniasis is most prevalent during 
the peak years of sexual activity (102). The route of transmission is almost exclusively by sexual 
intercourse. It has been estimated that 10-50% of Trichomonas vaginalis infection in women is 
asymptomatic (67, 90).   
Trichomoniasis has a wide spectrum of symptoms ranging from inflammation in the form of 
vaginitis, urethritis to malodourous frothy discharge alone with asymptomatic carrier state (24, 
102). The discharge is frothy yellow or green and mucopurulent (85). About 2% of infected 
patients present with "strawberry cervix" (24). Trichomoniasis is associated with serious 
complications. These include pyosalpinx, endometritis, and premature rupture of membrane, 
preterm labor and low birth weight (34, 70). Trichomonas vaginalis is associated with non 
gonococcal urethritis and prostatitis in men (48).  
There are several epidemiological studies done in India which shows that trichomoniasis is a 
major problem. Hospital based studies done in India showed that the prevalence of Trichomonas 
vaginalis as high as 61.7% in women attending STD clinic while as low as 6.7% among women 
with reproductive tract infections (1, 93).  
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Community based studies among women from different parts of India had shown prevalence for 
Trichomonas vaginalis varies from 13 - 34.3% (17, 83). A community based study among the 
spouses of women with Trichomonas vaginalis infection showed a prevalence of 47.5% (51). In 
a hospital based pregnant women population of Tamil Nadu the prevalence was found to be 6% 
(67).   
It is known that sexually transmitted infections (STI) facilitate the transmission and acquisition 
of other STI's including human immunodeficiency virus (HIV) (65). Measures like aggressive 
STI prevention, testing and treatment reduce the transmission of HIV. In studies done among the 
HIV seropositive and HIV seronegative women the prevalence of trichomoniasis was 9.4-29.5% 
and 8.2%-23.4% respectively in a group of female sex workers (19).  The incidence of 
trichomoniasis also found to be high among women compared to men among HIV infected 
individuals (42). Among   pregnant women infected and uninfected with HIV virus higher 
incidence of Trichomoniasis was present in seropositive than seronegative women (101). 
Trichomoniasis is a non notifiable infection and hence no public health programs have been 
directed towards controlling the infection (91). This disease plays an important role in social, 
medical and economical areas of the society. Majority of the women with trichomoniasis have 
been asymptomatic (67, 90) and in the absence treatment, infection is thought to persist for long 
periods (16).  
Currently there are different techniques available for the diagnosis of trichomoniasis.  The 
various clinical specimens that can be used for the diagnosis of infection include urine, vaginal 
fluid, semen and endo-cervical smear from women where as urethral discharge, prostatic 
secretions or urethral scrapings may be used for diagnosis in men (102). The most commonly 
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used methods for the diagnosis of trichomoniasis infection are wet mount preparation and culture 
(90).  Both these methods rely on visual detection of viable trichomonads with their 
characteristic motility (44). The wet mount preparation has shown to have a sensitivity of 35-
82% and a specificity of 95% (62, 91). The advantage of the wet preparation is that, it is 
inexpensive and rapid (22) while the disadvantage is that the sensitivity depends on the 
experience of the performer (62). There are different staining methods also in use for the 
diagnosis of the Trichomonas vaginalis.  Papanicolaou (Pap) smears have shown a sensitivity of 
61.4% (53). Other staining methods used are Giemsa, Romanowsky and Acridine orange (63). 
Though the above mentioned tests are rapid with sensitivity as that of wet mount preparation, 
they require skilled personnel, financial resource as well as good equipped laboratory (102). 
Broth culture is considered as a gold standard for diagnosis of trichomoniasis (17). There are 
several culture media available for the cultivation of Trichomonas vaginalis. The reported 
sensitivity for the culture is 85%-97% and the specificity varies from 94% to 100% (28, 62,103). 
The drawbacks of culture are its cost and duration of incubation is required for the growth of the 
organism. This period can be prolonged to 2-7days (24). Hybridization assay also has been also 
used for the diagnosis and has a sensitivity of 88-91% and a specificity of 100% (115). Even 
though this is a rapid test it requires heat block special processor which makes it expensive and 
suitable only for reference laboratories.   
Among the newer tests, a nucleic acid amplification method, like polymerase chain reaction 
(PCR) seems to be more practical in diagnosing T.vaginalis infection. PCR requires only DNA 
of viable or non-viable organism in very low concentrations (102). The sensitivities of various 
primers designed ranges from 85-100% (91). As compared to culture the results are available 
faster (62). 
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There is insufficient information from India on the prevalence of Trichomonas vaginalis 
especially among the HIV infected individual. The data on molecular diagnosis and its 
comparison with the widely available culture and wet mount preparation is lacking from India.  
Hence, this study is being undertaken to evaluate the role of polymerase chain reaction (PCR) as 
compared to wet mount and culture in the diagnosis of Trichomoniasis and also to look at the 
frequency of infection among HIV infected women.   
The hypothesis of the study was that the prevalence of trichomoniasis in HIV infected women is 
higher and PCR is a better alternative method for the diagnosis of trichomonas vaginalis.  
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2.0   AIM AND OBJECTIVES 
AIM  
To standardize and evaluate a Polymerase Chain Reaction (PCR) for the diagnosis of 
trichomoniasis. 
 
OBJECTIVES 
1. To standardize Polymerase Chain Reaction (PCR) for the diagnosis of Trichomonas  
Vaginalis in culture from clinical samples 
 
2. To evaluate the performance of the PCR in diagnosing trichomoniasis in the hospital 
 setting. 
 
3. To determine the prevalence of trichomoniasis in Human Immunodefiency Virus (HIV)  
positive women. 
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3.0 REVIEW OF LITERATURE  
3.1 HISTORY AND EVOLUTION 
Donné first discovered and named Trichomonas vaginalis in 1836 after finding the organism in 
genital secretions of both women and men (104). T. vaginalis Pathogenicity was initially thought 
to be non-pathogenic as majority of infected patients were asymptomatic (104). T.vaginalis is a 
parabasalid protozoan that branched before Kinetoplastids and other protozoa which has 
mitochondria. T. vaginalis lacks mitochondria.  It uses hydregenosome fermentative 
carbohydrate metabolism, where hydrogen is used as an electron acceptor.  
3.2 CLASSIFICATION: 
The taxonomic classification scheme of T.vaginalis was given by Dyer (91). According to this 
Protozoa with “9+2” flagellum, fall into the  
Phylum: Zoomastigina. 
Class:  Parabasalia - presence of parabasal body, [Golgi associated Kinetosomes, 
axostyle and undulating membrane] 
Order:   Trichomonadila 
They have 4-6 flagella which are free or attached to undulating membrane and they do not have 
true cystic form. 
17 
 
 
 3.3 GENERAL MICROBIOLOGY: 
Among all the Trichomonads, T.vaginalis is the most widely studied parasite. The size and shape 
of this protozoan is variable, the average length and width being 10 & 7 micron respectively 
(39). The protozoan parasite is pear shaped or oval in axenic cultures (11). It assumes an 
amoeboid shape when attached to the vaginal epithelium (35). 
It is a flagellated protozoan with five flagella, four of which are located in the anterior part of the 
parasite while the fifth flagellum is incorporated within the undulating membrane supported by 
non contractile costa (11,109). The parasite has a characteristic quivering motility imparted by 
the flagellum and the undulating membrane (39). During unfavorable growth conditions, 
T. vaginalis can round up and internalize the flagella. There are some who believe these forms 
could be pseudocysts, but it is more likely to represent degenerate forms of T. vaginalis as there 
are no reports of these giving rises to normal motile forms (27).  
The cytoskeleton of T. vaginalis is composed of tubulin and actin fibers. Investigators have used 
monoclonal antibodies to the tubulin molecule and found that the axostylar tubulin reacted with 
both sheep and pig brain tubulin (79). The nucleus is surrounded by a porous nuclear envelope 
and is situated at the anterior part of the parasite. The axostyle arising at the nucleus divides the 
parasite into two parts longitudinally and terminates at the sharp point at the posterior end of the 
parasite. The axostyle helps the parasite to adhere to the vaginal epithelial cells (39). 
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Granules called the hydrogenosomes are present in the paracostal and para-axostylar area 
(91,109). These are visible under microscope if the organism is alive. Glycogen granules are also 
present and can be visualized under electron microscope (109). 
3.4 REPRODUCTION AND LIFE CYCLE 
Trichomonas vaginalis has a poorly understood life cycle. The protozoan parasite is found to 
exist only in the trophozoite form There are varying developmental stages of trichomonas 
namely round forms which divide by amitotic budding division and small flagellated forms 
which divide by  longitudinal binary fission and their nuclear membrane remain intact. 
The process of division begins with duplication of selected loco motor organelles and the 
development of two attractophores on either side of the nucleus which are the poles for division.  
Chromosomal microtubules develop from the attractophores which grow towards and into the 
nucleus and attach to the centromeres of chromosomes. The paradesmose (extra nuclear 
spindles) elongate allowing the daughter cells to separate and develop the missing organelles (2). 
 3.5 EPIDEMIOLOGY: 
Trichomonas vaginalis infection is found to be prevalent globally with no seasonal or climatic 
variation. The overall estimated global prevalence of cases of Trichomoniasis is about 174 
million (114). The annual incidence of infections with Trichomonas vaginalis is 5 million in 
United States (65) and 76.5 million in South Asia and South East Asia (114).  
A study done in Baltimore (USA) among women attending STD clinic which showed 26% 
prevalence of Trichomoniasis (99). In another study based on race or ethnicity prevalence of 
Trichomonas vaginalis was reported as 23-51% between Africans-Americans, which is about 
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1.5-4 times more than other racial groups (99). In India, there are fewer studies done on T. 
vaginalis. Overall community based prevalence of T. vaginalis among women varies from 0.8 – 
34.3 % (17, 110) while the prevalence among married women varies from 4.3 – 27.4 % (83, 98). 
The prevalence of T. vaginalis in women attending sexually transmitted disease (STD) clinic 
varies from 5.9 – 17.2 % (20, 41, 49) while women attending gynecological out-patient 
department (OPD) from 0.4 – 26 % (13, 43, 78) and antenatal clinic from 3.8  – 15.7 % (67, 78, 
95).   
The prevalence of trichomoniasis among women by race in United States is highest (23-51%) 
among the African American women (99). A  Study done in USA among 216 HIV infected 
women, using cervico-vaginal lavage 25.2% were positive for T.vaginalis while 49.3% were 
found to have bacterial vaginosis (45). 
In another study done in the rural areas of Eastern Zimbabwe blood clots of 5521 women were 
taken to study co-infection with HIV and trichomoniasis. 516 (9.9%) were positive for 
T.vaginalis and among these 208 (40.3%) were positive for HIV while the remaining were 
negative for HIV (66).  
3.6 MODES OF TRANSMISSION: 
Human beings are the only natural host for T.vaginalis. Trophozoites are the infective forms and 
they are transmitted during sexual intercourse.  Among the male partners of infected women a 
high rate of infection has been found in prostate and urethra (47). This warrants treatment of both 
partners. The incidence of Trichomonas vaginalis is more among married and sexually active 
women than in postmenopausal and virgin females (79). These factors confirm that the infection 
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is transmitted sexually.  In rare situations non-sexual modes of transmission via douche nozzles, 
specula or toilet seats have been reported (113). In 2-17% of female babies born to women 
infected with T.vaginalis, the protozoan parasite has been found in their urinary tract or vagina 
(5). 
3.7 PATHOGENESIS  
T. vaginalis is the most intensely studied trichomonad and is one of the world's common cause of 
non-viral STDs yet the exact mechanism of its pathogenesis have not been clearly understood. 
Many mechanisms are thought to be involved such as, cell-to-cell adhesion (8) and the excretion 
of soluble factors such as extracellular proteinases (82) and cell detaching factor (CDF). 
T.vaginalis produces cell detaching factor that enables the detachment of the cell a monolayer in 
vitro (27). The interaction of T. vaginalis with the resident flora of the vagina is thought be an 
important factor that leads to the development of the disease (69). The host- parasite relationship 
is very complex and it is understood that single pathogenic mechanism cannot be responsible for 
the variety of clinical symptoms. All clinical isolates of T. vaginalis appear to be capable of 
infection and disease production (82).  
3.7.1 Adherence and Adhesins  
Adhesion of trichomonads to the vaginal epithelial cells is essential in the pathogenesis of the 
parasite (6). This depends on time, temperature, and pH. There is a mosaic of receptors for 
adhesion of host extracellular matrix proteins which help in ligand receptor binding (14).  The 
adhesion of the parasite to the epithelial cell is mediated by four adhesion proteins: AP65, AP51, 
AP33, and AP23 (10) which act in a specific receptor-ligand fashion (55).   AP65 is encoded by 
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at least three genes in a multiple-gene family (6) which is similar to the genes encoding for malic 
enzyme (77). The adhesins are expressed on the surface with a highly immunogenic glycoprotein, 
P270 (8). Contact of the parasite with the epithelium leads to amoeboid transformation, 
production of pseudopodia and up-regulation of adhesin synthesis.  Studies have shown that the 
side opposite to the undulating membrane and the recurrent flagellum of the parasite attaches 
itself to the epithelial cells (6). Laminin, localized in the basement membrane of the epithelium, 
promotes cell adhesion, differentiation, shape, and motility in normal cells, and also has 
chemotactic properties (84). But its role in pathogenesis of T.vaginalis is not clear.   
3.7.2 Hemolysins 
Since T. vaginalis, unable to synthesize lipids, erythrocytes may be the main source of fatty acids 
that are needed by the parasite. In addition to lipids, iron can be acquired by lysis of erythrocytes. 
For haemolysis to occur the presence of metabolically active parasite is necessary. Maximum 
hemolysis occurs in normal vaginal pH of 4.5.  Trichomonad can attach itself to the erythrocyte 
via a specific ligand receptor interaction and on attachment there will be release of perforin-like 
proteins which form pores in the erythrocyte membrane.  Finally, T. vaginalis detaches itself 
from the cell and cell lysis occurs. T. vaginalis has been observed to phagocytose erythrocytes. 
This property of hemolysis has been correlated to virulence of T.vaginalis.  
3.7.3 Contact-Independent Mechanisms of Pathogenicity and Cell-Detaching Factor 
It has been shown that a cell-free product of T. vaginalis contact dependent factor causes 
cytopathic effects in cell culture (27). Addition of cell-free filtrate of a T. vaginalis culture to a 
cell culture monolayer causes detachment and clumping the cells of the monolayer yet remain 
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viable. This is thought to be analogous to the sloughing of vaginal epithelial cells, seen in the 
vaginal mucosa during acute infections (27). CDF activity is probably a factor in pathogenesis. 
CDF, which is thought to be an extracellular factor and was found to be a 200-kDa glycoprotein 
which is heat and acid labile (6). Increasing production of CDF was associated with increased 
severity of clinical disease (27). CDF is also immunogenic. It is unclear whether the regulation of 
CDF production its activity, its immunogenicity play a role in the severity of symptoms.  All 
these pathogenic mechanisms are probably important in the virulence of this disease.  
3.7.4 Interaction with the vaginal flora  
T. vaginalis thrives in pH of higher than 5 but the normal pH of the vagina is a very acidic (pH 
4). The relationship between protective lactobacilli and T. vaginalis is not completely understood. 
It has been seen that with the rise in the vaginal pH there is either decrease or complete absence 
of Lactobacillus acidophilus and an increase in the number of anaerobic bacteria (69). It has been 
proposed that T.vaginalis may phagocytose L. acidophilus or the protienases and contact 
dependent factor secreted by T.vaginalis may destroy the bacteria (69).  
3.7.5 Immune System Evasion 
The ability to evade the host immune system is an important aspect of pathogenesis of 
T. vaginalis.  This organism avoids complement to overcome the activity of human immune 
system. It has long been known that T. vaginalis activates the alternative pathway of complement 
(30).  Cervical mucus is deficient in complement and the only source is the menstrual blood 
which has less of complement. Menstrual blood has appreciable complement-mediated 
cytotoxicity towards T. vaginalis. It was found that iron was a contributing factor in complement 
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resistance (9) has found that two classes of markers are alternately expressed on the surface of 
the organism: the highly immunogenic glycoprotein (P270) and the adhesins (AP65, AP51, 
AP33, and AP23) (77). The positive-phenotype (P270 positive) organisms lack adhesins and 
cannot cytoadhere or parasitize host cells (82). Only the organisms of the negative phenotype 
(P270 negative) which express adhesins have the ability to cytoadhere to the host cell (7). 
Adhesins of T. vaginalis has numerous other ways of evading the immune system. This parasite 
also secretes highly immunogenic soluble antigens which may neutralize antibody or cytotoxic T 
lymphocytes thus short-circuiting specific anti-T.vaginalis defense mechanisms. T. vaginalis can 
coat itself with host plasma proteins and does not allow the hosts immune system to recognize the 
parasite as foreign. Thus immune system mechanisms, such as presentation and antigen 
complement-mediated lysis do not occur (79). 
3.8 CLINICAL MANIFESTATIONS: 
Trichomoniasis presents with a number of different clinical patterns. The spectrum of clinical 
features may vary from asymptomatic carrier state to flagrant vaginitis. Within six months one 
third of asymptomatic women become symptomatic (85). Trichomoniasis is the disease of 
reproductive age group hence the clinical features are seldom observed before menarche or after 
menopause. T.vaginalis mainly infects the squamous epithelium of the genital tract and the 
infection in females lasts longer.  The incubation period on an average is about 4 to 28 days. 
Acute infection: Women with acute infection will have vaginal discharge which is frothy, green 
or yellow and muco-purulent associated with leucorrhoea (85). Edema and erythema is observed 
in 22-37%, along with pruritis and irritation.  The discharge may be malodorous with pH > 4.5 
(102). Small punctuate hemorrhagic spots appear in the mucosa of vulva and vagina which are 
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called colpitis macularis or strawberry cervix (91). The urethra may be infected in most women 
and they may present with lower abdominal pain and dysuria (91). 
Chronic infection: These women mostly present with mild vaginal discharge along with 
dysparunia and pruritis. Vaginal discharges in them are not classical. These groups of women are 
the major source of transmission of the parasite. There are several complications reported in 
women following trichomoniasis.  
a. Endometritis – T.vaginalis is thought to play a role in pelvic inflammatory disease. Cherpes 
et al (2006) investigated a relationship between endometritis and fallopian tube obstruction 
associated with T.vaginalis on 736 women by carrying out endometrial biopsy at enrollment and 
hysterosalpingography after 12 weeks. Women with infection with T.vaginalis had acute 
endometritis and more when associated with HSV-2 infection. 
b. Premature rupture of membranes: pregnant women who had T.vaginalis in their vagina 
more often have premature rupture of membranes. T.vaginalis carriers are 1.4 times more likely 
to develop premature rupture of membranes (70). 
c. Low birth weight- cervical infection with T.vaginalis has been shown to be associated with 
decreased gestational age at delivery. It has also been found that 50% cases of low birth weight 
are associated with asymptomatic trichomoniasis (34). 
d. Infertility- T.vaginalis has been suggested as the cause of infertility in males and females. 
Benchimol et al (2008) has demonstrated the effect of T.vaginalis on human sperms and it 
revealed that when the sperm cells were exposed to T.vaginalis over different period of time, the 
trichomonads first adhere to the surface of the sperm cells, render them non-motile and then 
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gradually phagocytose and digest them with the help of Lysozymes.  This is being thought as a 
mechanism of reproductive failure. A study done at Infertility Service of the National Institute of 
Endocrinology from June 1999 to June 2000, showed that out of 172 couples who visited this 
clinic for the first time, 10.5%were positive for the parasite where the women presented with 
leucorrhoea (87). 
e. Cervical erosion – Reproductive tract infections have been shown to be associated with 
inflammatory changes in the cervical epithelium and has shown that there is an association 
between reproductive tract infections and cervical epithelial changes. Among the studied women 
it was found that 80.5% had inflammatory epithelial changes and of these 18.3% were detected 
to have T.vaginalis infection (96). 
3.8.1 Clinical features in Men 
Men are generally considered as asymptomatic carriers of T.vaginalis and these can be identified 
by investigating sexual contacts with infected women.  Symptomatic men present with profuse 
purulent urethritis, while symptoms may simulate non-gonococcal urethritis (48). Complications 
in men infected with T.vaginalis include, prostatitis, balanloposthitis and epididmytis.  
3.9 TRICHOMONIASIS AND HIV 
Trichomoniasis is associated with HIV transmission. Presence of other STI’s makes the patient 
susceptible to acquire and transmit HIV by two to five folds (100). All over the world, 75% of 
human immunodeficiency virus type 1 (HIV1) are acquired through sexual contact (111).   
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Since 1986 when HIV was first identified in India it has been spreading as an epidemic 
throughout the country. As per the latest estimate the number of HIV infected individuals varies 
between 2-3 million with prevalence of 0.36% (75).  
Majority of the transmission i.e., about 81% of infection is transmitted through sexual contact, 
6% through blood and blood products, 5% through intravenous drug use and less than 1% from 
mother to child (106). 
 In a study conducted in Eastern Zimbabwe, to look into the epidemiology of T.vaginalis 
infection and its association with HIV, using serological assays, 40.3% women were found to be 
positive for T.vaginalis and HIV (66). The HIV seropositvity was significantly associated with 
being sexually active; having multiple sex partners, having a partner who had multiple sex 
partners, seropositvity was associated with a recent history of genital discharge (66). 
In a cross-sectional study conducted among 1,209 female sex workers in Ivory cost by bivariate 
analysis an association between HIV and Trichomonas infection showed a crude odds ratio 1.8, 
with 95% CI. In another cross-sectional study conducted in Tanzania among 359 women 
admitted to a hospital for gynecological conditions, Trichomonas was more common in women 
with HIV infection. Epidemiological studies have shown that ulcerative and non ulcerative 
sexually transmitted pathogens N.gonorrhoeae, T.vaginalis respectively are associated with 
increased risk of HIV-1 infection. Vigorous host immune response following physical trauma 
and damage from other sexually transmitted pathogens (STPs), compromise the integrity of 
mucosal surfaces thus potentially enhancing susceptibility to infection (33).  As a result of local 
inflammatory response there is an infiltration of leukocytes, including CD4+ bearing 
lymphocytes and macrophages to which HIV can bind and gain access (56). In HIV infected 
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person the factors mentioned above can increase the level of virus- laden body fluids and the 
number of HIV virus infected lymphocytes and macrophages in the genital area thereby 
increasing the probability of HIV exposure and transmission to the uninfected partner. Cervical 
inflammation has been found to be associated with increased cervical shedding of HIV (46).  
 Increased urethral viral loads have been documented in men with Trichomonas infection (38). 
T. vaginalis is able to degrade secretory leukocyte protease inhibitor which is known to block 
HIV cell attachment; this phenomenon may also contribute to HIV transmission (23). 
In a study done among the HIV seropositive and HIV seronegative women the prevalence of 
trichomoniasis was 9.4%-29.5% and 8.2%-23.4% respectively (19). This was a HIV 
epidemiology study done among 871 HIV- seropositive women and 439 HIV- seronegative 
women from four sites in USA. These women were followed for 5.5years.trichomoniasis was 
diagnosed on the basis of wet mount and culture on modified Diamond’s media. Like 
trichomoniasis, HIV infection is associated with low birth weight, premature delivery and 8-40% 
HIV transmission to neonates (110). Increased shedding of HIV in the semen with Trichomonas 
in urethera has been reported by Choen et.al [2002]. T.vaginalis is associated with increased 
human immunodeficiency virus (HIV) shedding in women infected with both T.vaginalis and 
HIV (50). 
3.10 DIAGNOSIS 
(i) Wet preparation: 
Diagnosis of trichomoniasis has traditionally depended on the demonstration of motile protozoa 
in vaginal and cervical secretions. This procedure was first described by Donne in 1836 
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Sensitivity is highly dependent on the expertise of the microscopist performing the test (62) 
Delay in transport processing of the sample in the laboratory may cause the organism to lyse or 
become non-motile (62). This method is inexpensive and can be performed rapidly (102). The 
minimum number of trichomonads required to appreciate the motility is 104(93). 
 
(ii) Culture:  
The “gold standard” test for the diagnosis of trichomoniasis has been culture in microaerophilic 
conditions (62). Several different media are available for culture. Most of the culture systems 
used is broth cultures (102). To initiate growth in culture the inoculums must contain at least 
300-500 trichomonad/ml (98). The interpretation of broth cultures is simple. 
a) Complex media 
This was first described by Kuldan, Honiberg, Frost and Hollander in 1970. This media was for 
routine propagation of organisms and also to provide inoculation for a more defined media. This 
media was supplemented with 10% horse serum (57).  
 b) Tissue culture media-CMRL 1066  
This is a modified tissue culture media.  The fact that T.vaginalis is intimately attached to host 
cells and is able to multiply in co- cultures with suitable cells. Based on this modified tissue 
culture media were developed (57): the CMRL 1066 (Parker, LaRoy & McCulloch, in 1957) and 
NCTC 135 (Evans, Bryant, Kerr& Shilling).  
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The doubling time of trichomonas in this media was fifteen hours as compared to complex media 
which is ten hours. Sub-cultured organisms can be cryo-preserved in liquid media (57). CMRL 
1640 is a modified tissue culture media prepared to supply cholesterol. This media contains 
commonly occurring fatty acids and bovine serum albumin to act as a stabilizer and supply all 
the other liquid factors. The doubling time of Trichomonas in this media is 14 hours.  
 c) Defined media 
In this kind of media concentrates of vitamin, amino acids and trace elements are added. Single 
strength media can be stored frozen at -20˚c for 3 months or at 4˚C up to two weeks. 
Concentrates in this media can be stored at -20˚C up to 6 months (57). 
  d) DL-7 and DL-8 
This is a very rich medium containing wide range of vitamins supplied by vitamin concentrates. 
It also contains purines, pyrimidines and amino acids.  Ascorbic acid and cystine in the media 
reduce the redox potential. T.vaginalis grows rapidly in this media supplemented with 8% FCS. 
The doubling time of trichomonads is about 11 hours. Serum in this media was replaced by ‘fatty 
acid poor’ albumin and Armour ‘fraction V ‘albumin. The growth results were successful (57). 
e)   Kupferberg’s STS Media Modified: 
This media was discovered in 1955 by Kupferberg and was called Kupferberg’s simplified 
“trypticase”serum (STS) medium. This medium was slightly modified later to help in the 
preparation of the media and to bring down the cost. The media constitutes of Maltose 1gm, 
Oxoid agar 2gm, trypticase (Baltimore Bilogical Laboratories) 20gm,  cystine hydrochloride 
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1.5gm dissolved in 1 liter of distilled water. 0.2ml of 0.5% Methylene blue is used as an 
indicator. After autoclaving the media is supplemented with 0.25ml of sterile serum containing 
100,000 units of penicillin and 20 mg of streptomycin. Advantage-S.T.S. media is a good 
transport medium and the positive cultures survive from 14-23 days (120). 
 
f) Diamond’s media modified: Klass modification 
This is a commercial media. The Remel Diamond’s media modified contains 12% horse serum 
(28). In a study done among 163 female patients attending Obstetric and Gynecology in Sinai 
Samaritan Medical centre, 32% patients were detected positive by modified Diamond’s media 
and 24.5% by Kupferberg medium (28). Between the two commercially available medium used 
for diagnosis of T.vaginalis, Diamond’s media modified proved to be superior (28). All the 
above mentioned culture media are liquid broth cultures. 
 g) Modified Columbia Agar (MCA) 
This is a solid medium used for cultivation of Trichomonas vaginalis. This media contains 
Columbia Agar which is dissolved in distilled water, autoclaved for 5 min. After cooling sterile, 
inactivated, Lamb serum along with malt extract and dextrose are added. This is also 
supplemented with Baneocin, Nystatin, Penicillin, Streptomycin and Chloramphenicol. About 
10ml of the mixture is poured into 6mm petri dishes. When kept at 4˚C media can be stored for a 
week (100).  In a study done in Austria in patients attending out-patient clinic, MCA showed a 
sensitivity of 98.5% to detect trichomonas vaginalis.  
h) In Pouch TV culture system 
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 The In pouch culture system (Biomed diagnostics, San Jose California) is a commercially 
available system which is used for detection of Trichomonas vaginalis. In this system both the 
wet preparation and the culture systems are combined together. The System contains two 
pouches. Two swabs are inserted from an opening on the top. The upper pouch is used for 
culture while lower pouch is for wet preparation (93, 98). In a study done among 601 women 
among women attending a primary health clinic in Ballabgrah, Haryana, 22 women were 
positive by wet mount and 40 by In Pouch culture which was statistically significant with a        
P <0.001 (93). Advantages of this media are, it is stable for 6 months at room temperatures, 
specimen transport and culture can be done in the same media. The specimen can even be mailed 
and remain viable for a week (15). The sensitivity of In Pouch TV compared to Diamond’s 
modified media is 97% (12). 
iii) Papanicolaou Test  
Papanicolaou staining has been used for screening genital infections and abnormalities. The main 
advantage of this method is that the samples can be stored permanently and can be reviewed 
later. Studies have shown that the sensitivity of this test ranges from 24%-67%. In a study done 
in Brazil, the specificity of Papanicolaou test was 97.6%, whereas sensitivity was only 60.7%. 
The positive predictive value of the Papanicolaou smear was 61.7% (58). There may be errors in 
diagnosis due to false positive and false negatives.  
The main purpose for staining trichomonads is to optimize the visualization of key anatomic 
structures for accurate identification of the organism (63).  Smears can be made from the vaginal 
discharge or cultures, after fixation stained with Giemsa stain, Silver stain, iron-hematoxyline 
and Acridine Orange (63).  
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iv) Gram stain  
G. Ewart Cree in 1964, first observed vaginal smears by doing Gram’s stain, and could visualize 
trichomonads, the nucleus, flagellae and axostyle. The method used to prepare the smears, is to 
dip a glass slide in the vaginal exudates in the posterior fornix and roll it over the exudate. 
Trichomonads appear gram negative and identified by lenticular eccentric nucleus and foamy 
cytoplasm (18). 
 
v) Xenostrip  
Xenostrip-Tv (Xenotope Diagnostics, Inc., San Antonio, Tex.) is an immunochromatographic 
strip test.  It is a qualitative assay used to detect T.vaginalis –specific antigen by colour 
immunochromatographic “dipstick” technology.  It is a rapid test as the results are ready within 
10-20 minutes (50). In this assay mouse antibodies are bound to nitrocellulose membrane. The 
sensitivity and specificity of this test are 66.7% and 100% respectively (81). The Xenostrip rapid 
assay is useful in settings where prevalence of infection with T.vaginalis is moderate and 
microscopy is not possible (50). 
vi)  Latex agglutination tests 
This test can be done on vaginal swabs. Kalon TV latex agglutination test (Kalon Biological, 
Surrey, UK) is used. Vaginal swabs are eluded in phosphate buffered saline by agitation. Mix 
one drop of this elude with one drop of latex on a black glass slide. Slide is rocked for 2 minutes. 
Agglutination indicates presence of T.vaginalis antigen(3). In a study done by Y Adu Sarkodie et 
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al among 3807 consecutive women in antenatal clinic at Ghana to compare wet mount culture 
and latex agglutination showed the sensitivity and specificity very much comparable to culture 
and far superior to wet mount (3). 
 
vii) Molecular methods 
Molecular probe for identification of Trichomonas vaginalis DNA. In a study done by Salvatore 
et.al a 2.3Kb DNA fragment of Trichomonas vaginalis was present in strains from diverse 
geographical regions were cloned (88) and DNA in vaginal discharge was detected using dot and 
blot hybridization technique. The probes used were Pros21, and Ppat22. These were 
radioactively labeled using random priming kits.  Autoradiographs were prepared with Kodak 
diagnostic films. Disadvantages of this technique are the probe has some drawbacks like, 
radiolysis makes the probe instable, autoradiographic procedures are time consuming and 
preparation of clinical samples should correct handling and disposal of radioactive material (72). 
Affirm VP Microbial identification test is a semi-automated commercial system (MicroProbe 
Corporation, Bothell, Wash) used for diagnosis of bacterial vaginosis and Trichomoniasis. In this 
assay synthetic oligonucleotide probes are used to detect G.vaginalis and T.vagnalis can 
simultaneously. Compared to culture and PCR the Sensitivity and specificity were 83% and 
100% respectively (64). 
Another molecular technique used is the fluorescent DNA In situ Hybridization. This is a 
technique in which the chromosomes of different organisms can be identified when a double 
stranded DNA is denatured and the single strand is exposed to a known nucleotide probe which 
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is labeled.  This probe binds to the single strand and can be recognized by their fluorescence. In a 
study conducted by Ferris et al (1995), 501 symptomatic women were tested for T.vaginalis and 
candida using wet mount, pH and in situ hybridization. Trichomoniasis was detected in 7.4% by 
in situ hybridization method.  The sensitivity and specificity was 86.5% and 98.5%, for T. 
vaginalis compared to culture. 
Polymerase chain reaction (PCR) is a laboratory technique used for “amplifying” a specific DNA 
sequence. PCR is extremely sensitive and efficient and can make millions of copies of a specific 
DNA.  Limitations of culture and microscopy led to the development of PCR in diagnosis of 
Trichomonas vaginalis infection.  
Various studies have been done using different primers with different sensitivities and 
specificities (54). The sensitivity and specificity with these primers using vaginal swabs are 
varied sensitivity being 80 to 100% and sensitivity 88 to 100%. PCR has been performed on 
different types of clinical samples most commonly vaginal swabs and urine. PCR requires DNA 
of either viable or non viable organisms in very low concentrations (102). PCR of vaginal swabs 
may be useful in places where culture is not feasible in settings where self collection is utilized. 
There are a number of primer sets that have been used as discussed above and these can be used 
to detect different genes or sequences of T.vaginalis each having a different product size. Primer 
set TVA5/TVA6 detects A6P sequence of adhesin gene with a product size of 102bp, BTUB9/2 
to detect beta tubulin gene with a product size of 112bp, TR5/TR6 detects T99 sequence with an 
expected product size of 154 bp, TR7/TR8 target T17 rp with a product size of 146 bp, TVK3/7 
detects 312bp sequence from repetitive DNA and AP65 1/2 detects adhesin protein 65 encoding 
65 KDa protein with a product size of 209 bp. 
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Colorimetric One –Tube Nested PCR: 
This nested PCR was developed by Men-Fang Shaio et al (1997)  from Taiwan.  In this PCR, 
650bp specific DNA repeats (Tv- E650) from T.vaginalis genome were targeted for 
amplification. The final product size amplified was 290bp. Four primers were used, from 
conserved region of T.vaginalis genome. They are outer primers1&2 (OP1/OP2) and inner 
primers 1and 2(IP1/2). The labeled inner primer sequence incorporated in the PCR product was 
captured in an avidin –coated microtiter plate and detected by antidigoxin alkaline phosphatase 
conjugate (94).  Shaio et al. (1997) evaluated this nested PCR method by testing 378 vaginal 
discharge from symptomatic women. PCR and culture was positive for 31 samples.  Among the 
113 asymptomatic women tested 9 were positive by PCR, 2 of these were positive by wet mount 
and culture (94). 
Recently a TaqMan –based real-time polymerase chain reaction also developed for the diagnosis 
of trichomoniasis. A study in which vaginal swabs taken from 119 women were tested by 
TaqMan based real time PCR and compared with wet mount and conventional PCR. This study  
showed that conventional PCR done on vaginal washings and urine had a sensitivity of 100% 
and 56.4% respectively while that for real time PCR for same samples were 100% and 76.7%. 
The specificity of both these tests were100% & 97.6% for vaginal washings and 82.9% & 97% 
for urine respectively (80). 
3.11 TREATMENT OF TRICHOMONIASIS 
Infection caused by Trichomonas vaginalis has been treated using topical vaginal preparations. 
These preparations give symptomatic relief but are unable to cure the disease (60).  Local 
preparations do not penetrate the vaginal epithelium, urethra, Skene’s gland and Bartholin’s 
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gland where the infection is usually found (60) some local preparations include, clotrimazole, 
providone- iodine, nanoxynol 9 and some arsenical pessaries (60).  There are no topical 
treatments for men (60). 
After the discovery of Metronidazole in1959, it has remained the drug of choice for the treatment 
of Trichomonas vaginalis (97). Metronidazole (alpha–hydroxyethyl-2-methyl-5-nitroimidazole) 
is a 5-nitroimidazole, a heterocyclic compound with a nitro group on the fifth position of 
imidazole ring. It is a derivative of Streptomyces antibiotic azomycin (73).  
Metronidazole is a prodrug and needs to be activated in susceptible organisms (73). The drug 
enters the cell membrane of T.vaginalis by passive diffusion and is activated by its reduction 
nitro group (cytotoxic nitro radical anion) (73). Transient binding of this nitro group to DNA 
causes, disruption and breaking up of strands leading to cell death (63). In E.coli, this DNA 
damage due to direct binding of the drug can be repaired by excision pathway which is not 
activated in T.vaginalis (89). Studies have shown that action of metronidazole is associated with 
thymine and thymidine phosphates (79). Since the genome of T.vaginalis has about 71% of 
A+Tcontent this parasite is attracted to metronidazole (89). The organanelle contains electron 
transport components linked to private: ferroxidine oxidoreductase (PFOR) which is responsible 
for activation of metronidazole (89).  
When taken orally or intravenously, the bioavailability of the drug is 93-100% (116) which 
vaginal absorption of the drug in vagina is low with a bioavailability of 20% (89). Absorption of 
local preparations of metronidazole in the vagina are affected by, drug formulation (insert or 
cream), dose and physicochemical nature of the vagina at the time of treatment (89). 
3.11.1 Treatment Regimens 
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Centers for disease control and prevention guidelines recommend 250mg three times a day for 7 
days, 500mg twice a day for 7 days or a single dose of 2-g dose. Considering the patient 
compliance a 2-g oral dose has been considered adequate for the cure of Trichomonas vaginalis 
infection (59). Though unlike the treatment duration of 7 days, this regimen does not protect 
against re-infection unless both sexual partners are treated simultaneously. Cure rates of oral and 
intravenous regimens is 85 to 95% (59). 
3.11.2 Treatment of pregnant women and lactating women- A single dose of metronidazole 
2gm orally is the current treatment recommended by CDC in all stages of pregnancy. Daily 
intravaginal dose of 100mg clotrimazole for 6 days can be used for temporary relief during first 
trimester followed by metronidazole in second trimester has also been recommended (89).  
A single dose of 2-g orally followed by a 24 hour interruption in breast feeding is recommended, 
thus preventing the exposure of the neonate to the drug (89). 
Neonates-Neonatal trichomoniasis depends on the maternal estrogen level, having a spontaneous 
resolution as the level of estrogen comes down by third to sixth week.  In children with persisting 
infection for more than six weeks or in presence of symptoms, the infant must be treated with 
metronidazole as single dose 50 mg/Kg or 10-30 mg/Kg daily for 5-8 days (89). 
3.11.3  Metronidazole resistance: 
Trichomonas vaginalis develop resistance to metronidazole either aerobically by oxygen 
scavenging pathways (79), or ferroxidine pathway (109) and aerobically by reduction or 
cessation of PFOR and hydrogenase (89). At least 5% of infections caused by T. vaginalis are 
due to strains which low or moderate resistance to metronidazole (74). After ruling out all the 
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causes of treatment failure a possibility of resistant T.vaginalis infection must be considered. 
Metronidazole susceptibility test must be done in all suspected cases. Relapse of infection in 
patients in whom non-compliance and re-infection should be ruled out.  Factors which are 
responsible for relapse are, low zinc concentration in serum (115), inactivation of metronidazole 
by vaginal bacteria and ineffective delivery of drug to the vagina. These patients can be treated 
using the following protocol (4).  
There are reports of refractory case as well. A refractory case is defined as cases in which two 
standard courses of treatment fail to cure the infection. To treat these cases, doses of oral 
metronidazole can be increased along with the extension of the course, which has been found to 
be effective in 80% of patients (74).  These patients can be treated according to protocol 
described above (4). The treatment can be combined with vaginal clotimazole, arsenical 
pessaries, betadine douches and Solco Trichovac Lactobacillus vaccine (89).  
Tinidazole 
Tinidazole a 5- Nitroimidazoles compound is also used for the treatment of trichomoniasis.  The 
half life of this drug is longer than metronidazole (68). The concentration of Tinidazole in the 
vaginal secretions is equal to that in the serum. Since the cross resistance between 
Nitroimidazoles is incomplete (74), Metronidazole resistance trichomoniasis can be treated with 
Tinidazole.  In a study done at CDC on metronidazole susceptible and resistant T.vaginalis 
isolates, Tinidazole was effective against all metronidazole susceptible strains but killed only 3 
of 12 metronidazole resistant strain (74). While Furazolidone was very effective for both strains 
of T.vaginalis in 2 to 3 hrs of exposure (74).  
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Other Nitroimidazoles compounds like Orinidazole and Secnidazole have a longer half life and 
lower rates of elimination. In a study among 20 women with trichomoniasis infection, a single 
dose of 2g was able to cure all patients (97). The other treatment option is the Nonimidazole 
chemotherapeutic agents, Hamycin.  This is an aromatic polyene related to amphotericin B. This 
drug binds to ergosterols in the plasmalemma, which helps in formation of pores. There is 
leakage of the cytoplasm which leads to cell death.  Hamycin in low concentrations kills both 
metronidazole sensitive and resistant strains of T. vaginalis.  This drug is being used in India as 
topical treatment of trichomoniasis (117).  
3.11.4 Vaccines 
The rise in the number of refractory cases, and lack of alternative treatment, disease prevention 
with vaccine is considered. T.vaginalis does not induce long term immune protection (89). Thus 
the vaccine did not show any direct immune or antibody response to T.vaginalis. The vaccine 
stimulated an increase in non specific immune factors relieved the symptoms and removed 
infection. A Lactobacillus vaccine called Solo Trichovac was introduced by a Swiss company, 
Solco (Basel). This is a systemic vaccine containing eight aberrant strains of Lactobacillus 
acidophilus which had been isolated from T.vaginalis infected persons. The efficacy of this 
vaccine is 90-100% (32) 
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4.0 MATERIAL AND METHODS 
The study protocol was approved by the institutional review board. The study had two parts. The 
first part of the study was to standardize a non-nested PCR for the amplification of the one of the 
Trichomonas vaginalis gene and to evaluate its performance on frozen culture positive and 
culture negative samples.  The samples for these culture supernatants were collected from 
women, who had presented with vaginal discharge. These women belonged to a rural area looked 
after by the community department of Christian Medical College. The vaginal swabs from these 
women were collected between the year 2005- 2006 and inoculated into modified Diamond’s 
media.  
After checking the media for growth for 10 days, the culture supernatants (2ml) were aliqouted 
in screw capped vials and stored at -20˚c.  A total of 30 culture positive samples and 40 culture 
negative samples were included for the evaluation of the PCR. 
For standardization of polymerase chain reaction culture concentrates and culture supernatants of 
two stored aliquots, one each of positive and negative culture of Trichomonas vaginalis were 
used.  
In order to prevent PCR amplification product carry-over contamination, DNA extraction, master 
mix reagent preparation and handling of post amplification products were carried out in separate 
rooms designated for each of the above mentioned purposes. Each room had dedicated pipettes 
and tips with aerosolized barrier. 
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4.1 DNA Extraction:  
DNA from T.vaginalis culture was extracted using CHELEX method (62). One and a half ml of 
stored culture supernatant was centrifuged in a micro centrifuge at 1000 rpm for 1 minute. 
Subsequently the supernatant and concentrates were separated out. For standardization, DNA 
was extracted from undiluted culture supernatants, undiluted and 1 in 10 dilutions of the 
concentrates. Fifty micro litter of the culture supernatant (neat sample), and 50µl of the 
concentrate was transferred to two 1.5ml tubes. The 1/10 diluted concentrate was prepared by the 
addition of 50µl of the concentrate to 450µl of sterile water. Fifty micro litter of this diluted 
concentrate was also taken in a 1.5 ml tube. Subsequently 200µl of 5% suspension of chelating 
resin (chelex 100, Sigma Aldrich, Steinhein, USA) in Tris buffer (0.01MpH 8.0) was added to 
these three tubes. This mixture was incubated at 56˚C in a water bath for 30 minutes, followed 
by gentle vortexing. Subsequently this mixture was boiled in a water bath at 100˚C for 10 
minutes and then centrifuged in a micro centrifuge at 1200g for 1 min. The extracted DNA was 
stored at -70˚c in multiple aliquots (62). Just prior to the PCR an aliquot was taken centrifuged in 
a micro centrifuge at 1200g for 1 min. The supernatant was discarded and the pellet was 
reconstituted in about 50µl of the remaining supernatant in the tube. The required DNA input 
was taken from this tube.   
4.2 Polymerase Chain Reaction (PCR): 
For standardization of the non nested PCR two sets of primers were tried. The first set using the 
TVA5/TVA6 which amplifies a 102 bp genomic sequence of adhesine gene (62). The second set 
of primer used was BTUB9/2, which amplify 112bp genomic sequence of beta tubulin gene. 
 The sequences of the two sets of primers used were shown in Table 4.1.   
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Table 1.  Nucleotide sequences of the primers used for T.vaginalis amplification 
Primer Name Nucleotide Sequence Region 
amplified 
Product 
size 
Reference
First set of  
PCR 
Primer 1: TVA5 
Primer 2: TVA6 
2nd set of primer 
Primer 1: 
BTUB9 
Primer 2: 
BTUB2 
 
  
5’GATCATGTTCTATCTTTTCA3’ 
5’GATCACCACCTTAGTTTACA3’ 
 
5’CATTGATAACGAAGCTCTTTACGAT3’
5’GCATGTTGTGCCGGACATAACCAT3’ 
 
 
A6p 
 
 
 
 
 
btub1,2 and 3 
 
 
 
102bp 
 
 
 
 
 
112bp 
 
 
(62) 
 
 
 
 
 
(62) 
 
The Master Mix was set up to a final reaction mixture volume of 40µl by adding sterile distilled 
water. For each reaction 10µlof DNA template was added. The concentration of the each 
reagents used for the preparation of master mix is shown in Table 4.2. After the addition of DNA 
the tubes were lightly vortexed and then centrifuged in a micro centrifuge and kept in thermal 
cycler. (AB Applied Bio systems, Gene Amp PCR Systems 9700,USA)  
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Table 2.  Master Mix PCR reagents used per sample for the first and second primer sets for 
the PCR 
Reagent Volume Final concentration 
PCR Buffer 5µl 1x 
MgCl2 5µl 1.5mM 
Primers 2µl each 25p moles each 
DNTPs 1µl 0.1Mm each 
Taq polymerase 2µl 3.5 units 
DNA 10µl 5µl 
Final Volume 50µl  
A touchdown method for thermal cycling was used. The thermal cycling condition is given in 
Table 4.3. Annealing temperature begins at 62˚C and ended at 52˚c for 45secs Annealing 
temperature was lowered by 1˚C for every 4 cycles until reaching 52˚c. The total time taken for 
the assay was approximately 5 ½ hours.  
Table 3.  Thermal Cycling Conditions used for the PCR: 
 Temperature Time Cycles 
1st PCR 95oC 75sec 1 
  95oC 
62 oC-52 o C* 
72oC 
45sec 
45sec 
45sec 
60 
  72 o C 7 min 1 
* Annealing temperature was lowered by 1˚c for every 4 cycles until reaching 52˚c. 
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 Temperature Time Cycles 
1st PCR 95oC 75sec 1 
  95oC 
62 oC-52 o C* 
72oC 
45sec 
45sec 
45sec 
60 
  72 o C 7 min 1 
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4.3 Detection of amplified targets: 
The product of the PCR was checked for amplification by eletrophoresing in 2% agrose (Sigma 
Aldrich, Steinhine, USA) gel incorporated with 10μg/ml (0.01Mm)(62) of ethidium bromide. 
The electrophoresis was carried out in a submarine gel unit at 120 volts.  Following the 
electrophoresis the gels were viewed in an UV transilluminator and documented using the gel 
documentation system (BIO-RAD, California, USA).  The expected size of PCR product was 
102bp for the adhesion gene and that for Beta tubulin gene was 112bp .The size of the amplified 
product was assessed by comparison with 50bp molecular marker (Fermentas Life Sciences, 
Canada, USA).  
After standardization using the best performed primer set the test was evaluated with 30 positives 
and 40 negative culture supernatants. The statuses of the culture were blinded to the performer of 
the test. After completion of the testing of 70 culture proven samples, the numbers were decoded, 
and the results were compared with culture. For the analysis culture is considered as the “gold 
standard “for the diagnosis of trichomoniasis. On comparison the results were found quite 
unsatisfactory. It was decided to use a different PCR reagent i.e., HotStar Taq Master Mix 
(QUAGEN, Hielden, Germany) from another commercial source. 
The reaction mixture was mixed well and then 5µl of DNA template was added to each tube. The 
final volume of the reaction mixture was 25µl. The mixture was well centrifuged in a micro 
centrifuge at 1000rpm /min for 1 minute, and the tubes were placed in the thermal cycler. The 
HotStar Taq Master Mix reagents used per sample for the PCR assay is shown in Table 4.4. 
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Table 4.  HotStar Taq Master Mix PCR reagents used per sample  
Component Volume/reaction Final Concentration 
HotStar Taq Master Mix 12.5µl 2.5units HotStar Taq DNA Polymerase 
1Xpcr Buffer 
200µM of each Dntp 
Primers 0.25 each 25pmol/reaction 
RNase –Free water 7µl - 
Template DNA 5µl - 
Total volume 25µl - 
 
4.4  Prospective study in HIV infected women 
The second part of the study was a prospective study to detect the prevalence of Trichomoniasis 
among HIV seropositive women. Vaginal swabs were collected from women attending infectious 
disease (ID) clinic of Christian Medical college Hospital and the hospital attached to the 
Community Medicine Department (CHAD). Though it was proposed to collect consecutive 
samples because of some logistic reasons there was a break in the sample collection and hence 
the sampling used was only a convenient sampling method. The study period was from the 
month of June 2006-Feburary 2007 and later again from Nov.2007-July 2008.  
4.4.1 Sample size: 
Sample size for the prevalence study of trichomoniasis among women with HIV seropositivity 
was calculated based on three Indian studies done by Mathai et al (1998) Divakar et al (2000) 
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and Sharma et al (1991) using a prevalence of 6% and desired precision of 3.5% with 95% C.I. 
The minimum number of samples to be tested was 177 (Epi info.ver.6.04).  
 4.4.2 Inclusion criteria  
All HIV sero-positive women who attend the infectious disease clinics at the main hospital or the 
community hospital for the first time. The HIV seropositvity was confirmed by NACO testing 
strategy III using three tests.   
4.4.3 Exclusion criteria: 
Women whose HIV serology confirmed negative at our institution were excluded from the study. 
Two hundred and four women attending the infectious disease clinic for the first time were 
recruited in the study with a written informed consent.  Vaginal discharge was collected by the 
physician using 3 cotton swabs stick from the posterior vaginal fornix under vision. One swab 
was used to prepare wet mount preparation to check for the motility of the parasite. Wet mount 
was checked in the laboratory attached with the ID clinic using a microscope at 10X and 40X 
objective respectively by the technicians in both ID clinic at the main hospital and community 
hospital (CHAD). 
The second swab was inoculated into the culture broth (Diamond’s media) while the third swab 
was inoculated into 2ml of sterile normal saline and stored at -20˚C for PCR. 
The inoculated culture broth was incubated at 37oC, and was checked for 10 days, by making wet 
preparation from broth to check for characteristic quivering motility of the trophozoites of 
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Trichomonas vaginalis every day.  The swab sticks inoculated in the media were squeezed and 
discarded after 24 hours of incubation at 37˚C. 
The third swab in 2ml saline was vortexed and discharge from the swab was washed in saline. 
After discarding the swab, the washed saline was aliqouted into 2 ml screw capped vials and was 
stored at -20oC for PCR. 
PCR was then preformed on vaginal discharge stored in saline. The sample was centrifuged and 
the DNA was extracted from the concentrate as mentioned in section 4.1 the protocol of PCR 
and the cycling conditions remained same as the one used for the evaluation of 70 culture proven 
samples with HotStar Taq DNA (Quaigen, Hielden, Germany). Negative water controls were 
used after every fifth samples. In order to avoid product carry over the PCR was set up in a 
separate room away from area involving amplified target sequence, thermo cycling areas, and 
PCR product storage and gel electrophoresis. Separate pipetting devices were used to set up 
PCRs and aerosolized barrier pipette tips were used.  
Adjudication of discrepant samples (those found to be culture negative and PCR positive or PCR 
negative and culture positive) was done by repeating the PCR three times. A sample was 
considered to be T. vaginalis positive if, at least on two occasions PCR results were positive.   
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4.4.4 Preparation of Modified Diamond’s Media: 
Commercial Trichomonas base (Himedia-M1204) was used for preparing the media. This base 
contains the following ingredients: 
Casein enzymic hydrolysate     17 gm/lt 
Papiec digest of soybean meal       3 gm/lt 
Liver digest           18 gm/lt 
Glucose           2.5 gm/lt 
Sodium Chloride           5.0 gm/lt 
Di potassium hydrogen phosphate         2.5 gm/lt 
Calcium Panthothenate            0.005 gm/lt 
Chloramphenicol             0.125 gm/lt  
 Sterile sheep serum (inactivated)             10 ml/ 100ml 
 Streptomycin sulphate             0.1/ 100ml 
 PenicillinG (100,000U)            0.6 gm/100ml 
 
Procedure:  
The media was prepared by the addition of 8.17 gm of Trichomonas base to 90 ml of distilled 
water. Subsequently this mixture was heated till the media is completely dissolved. The pH of 
the media was adjusted to 6.2 ±0.2 followed by autoclaving the media at 121˚C at 15 Ib pressure 
for 15 minutes and cool it to 45˚C - 50˚C. This is followed by the addition of 10ml of heat 
inactivated sheep serum (inactivated at 56˚c for 30 minutes) and antibiotics (Penicillin G and 
Streptomycin sulphate) to the media and mixed well. Five milliliter each of this final media was 
dispensed in screw capped tubes and stored at 4˚C. 
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4.4.5 Quality checking of the media 
Media was prepared in batches. Since ATTC Strains were not available, the quality of the media 
was checked by sub-culturing 2ml of the positive cultures in the previous batches into two tube 
of media prepared in the new batch and checking for motile trichomonads. 
4.5 Statistical analysis: 
The accuracy indices of the PCR and the wet preparation in comparison with the broth culture in 
Diamond’s media were calculated by using the software Epi info.Ver6.04. The difference in the 
proportion of the positive samples in asymptomatic and symptomatic HIV infected women were 
analyzed by Ch2 test using the software Epi info.Ver6.04.  The Kappa coefficient analysis to 
compare the agreement between the performance of culture and the non-nested PCR was carried 
out by the software Epi info.Ver6.04. 
53 
 
 
 
 
 
 
 
RESULTS 
 
 
 
 
 
 
54 
 
 
5 . RESULTS 
 5.1 Standardization of PCR  
The first set of primers (TVA5/ TVA6) amplified the Trichomonas vaginalis DNA from all the 
three samples i.e., undiluted supernatant, undiluted concentrate and 1/10 diluted concentrate. The 
expected band size for the product was 102bp. The second set of primers, Beta tub9/2 also 
showed amplification with all the three samples with different dilutions used. However, the 
undiluted concentrate showed a very weak band.  PCR was repeated with same sample and 
primer set Beta tub9/2 where two concentrations of primers were tried, 25mM/ reaction and 
10mM/ reaction, the concentration of other reagents as well as cycling conditions remained 
same. There was no improvement in the results. The gel picture showing the Trichomonas 
vaginalis specific bands with different concentrations of samples with the two sets of primers 
used are shown in Figure 1.  
Since the results with the TVA5/TVA6 primer set was better than the Beta tub9/2 primer set it 
was decided to continue the study with TVA5/TVA6 set of primers. 
5.2 Evaluation of the PCR with Trichomonas vaginalis culture proven sample  
PCR on 70 culture proven samples were done using the primer set TVA5/TVA6. Among the 30 
culture positive samples only 13 (43.3%) were showed an expected band size (102bp) while 
among the 40 culture proven negative samples 39 were negative. The accuracy indices obtained 
for this assay when compared to the culture results is shown in Table 1.  
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Figure 1: The Gel picture showing the Trichomonas vaginalis specific bands with different 
concentration of culture proven samples with the two sets of primers used in the study 
  
Lane 1 - 4 with primer set TVA5/ TVA6 (102bp) while lane 5-8 primer set beta tub 9/2(112bp) 
Lane 1   neat sample (culture supernatant) 
Lane 2  concentrated sample (deposit of the centrifuged culture supernatant) 
Lane 3  diluted sample (1/10 dilution of the concentrate) and  
Lane 4   negative control 
Lane5   neat sample (culture supernatant) 
Lane 6  concentrated sample (deposit of the centrifuged culture supernatant) 
Lane7  diluted sample (1/10 dilution of the concentrate) 
Lane 8  negative control and                     Lane 9   Molecular weight marker 
 
2 3 5 6 7 4 8 1 
112 bp   102 bp   
100 bp ladder 
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Table 1: The accuracy indices of the Trichomonas vaginalis PCR assay using Taq 
polymerase, Nucleotides and buffer mixtures (Ferments life Sciences, Canada, USA)  
 
T.vaginalis Culture status   
POSITIVE NEGATIVE 
POSITIVE 13 1 T.vaginalis  
PCR  assay NEGATIVE 17 39 
 
SENSITIVITY    43.3%  (26.0 –62.3) # 
SPECIFICITY    97.5% (85.3 – 99.5) 
POSTIVE PREDICTIVE VALUE  92.9% (64.2 – 99.6) 
NEGATIVE PREDICTIVE VALUE 69.6% (55.7 – 80.8) 
 
# Figures in parentheses are the 95 % confidence interval values 
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Figure 2 shows the gel picture showing the Trichomonas vaginalis specific bands with culture 
positive and culture negative samples with first set of PCR reagents (Ferments, Life Sciences, 
Canada, USA)   
As the PCR assay showed less than 50 % sensitivity with reagents used, it is decided to use a 
hotStar Taq Master Mix from another commercial source (Qiagen, Hilden, Germany). Two 
positive cultures, ID No. HP162 and ID No. HP165 which had shown bands in the assay with the 
earlier reagents were used.  A positive and a negative control were also included in the run.  Both 
the 25µl and 50µl PCR reactions showed band with the two known positive samples and the 
controls were satisfactory. Figure 3 shows gel picture with Trichomonas vaginalis adhesion 
gene specific bands in 50µl and 25µl reaction PCR assay done on culture positive samples. 
Both the 25µl and 50µl PCR reactions showed bands with similar brightness for both the test 
samples and the controls.  Subsequently all the 70 culture proven samples were tested with 25µl 
reaction mixture using the HotStarTaq master mix (Qiagen, Hilden, Germany) reagents. Among 
the 30 positive samples 29 were found to be positive for Trichomonas vaginalis adhesion gene 
product.  Of the 40 culture negative samples all were negative except one. Figure 4 shows gel 
picture of the PCR assay done on culture proven samples with HotStar Taq Master Mix.  
The accuracy indices of the Trichomonas vaginalis PCR assay with HotStarTaq master mix 
reagents (Qiagen, Hilden, Germany) compared to culture results are shown in Table 2. 
58 
 
 
Fig 2: The Gel picture showing the Trichomonas vaginalis specific bands with culture 
positive and culture negative samples (first set of PCR reagents).  
 
 
 
Lane1     molecular weight marker 
Lanes 6, 11, 17   negative water control 
Lane18    positive control 
Lanes 2, 3, 4, 5, 7, 8, 9, 10, 12, 13, 14, 15, 16  blinded cultures 
102 
100  
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Fig 3: The gel picture showing the Trichomonas vaginalis specific bands in the 50 µl and the 
25 µl reaction PCR assay done on culture positive samples.  
 
 
Lane 1  Molecular weight marker 
Lanes 2 Id No. HP162 
Lane 3  Id No. HP165   
Lane 4  Positive control of culture proven samples in 50µl reaction.  
Lane 5  Negative control 
Lanes 6  Id No. HP162 
Lane 7  Id No. HP 165 
Lane8  Positive control of culture proven samples in 25µl reaction. 
150 bp 
102 bp 100 bp 
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Figure 4: Gel picture of PCR assay done on cultures proven samples with HotStar Taq 
Master Mix. 
 
 
 
Lane1-molecular weight marker, 
 Lanes3,5,7, blinded culture samples with Trichomonas vaginalis specific bands 
Lanes 8, 15 , - negative control water 
Lane 16-Positive control 
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Table 2: The accuracy indices of the Trichomonas vaginalis PCR assay with HotStarTaq 
master mix reagents (Qiagen, Hilden, Germany) 
 
T.vaginalis Culture status   
POSITIVE NEGATIVE 
POSITIVE 29* 1 T.vaginalis 
PCR  assay NEGATIVE 1 39 
*two samples amplified only after testing with 1/10 diluted DNA 
 
SENSITIVITY    96.7%           (80.9. – 99.8) # 
SPECIFICITY    97.5%           (85.3 – 99.9) 
POSTIVE PREDICTIVE VALUE   96.7%           (80.9 – 99.8) 
NEGATIVE PREDICTIVE VALUE  97.5%           (85.3. – 99.9) 
 
# Figures in parentheses are the 95 % confidence interval values 
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5.3 Determination of the frequency of Trichomoniasis infection among the prospectively 
collected samples from HIV infected women attending infectious disease clinics  
A total of 204 women were recruited in to the study. Among this 2 were found to be HIV 
negative on repeat testing. From 2 individuals, swabs which were to be collected for the PCR 
assay were not done. There was over spillage of sample from the tubes and hence discarded.  
Samples from these 6 individuals were excluded for the study analysis.  
 5.3.1 Source and Demography of study participants  
Out of the 198 women 28 (14.1%) were recruited from the infectious disease (ID) clinic of the 
community hospital (CHAD) while 170 (85.8%) were taken from ID clinic of the main Christian 
Medical College, Hospital. This data is shown in Table 3. 
Among 198 study recruits, majority of the patients belonged to the states from southern India 
180 (91%) The region wise distribution of the study recruits is shown in Figure 5 
All the four South Indian states and the one union territory had a representation among the 198 
women included in the study. Majority of the patients belonged to Tamil Nadu 140 (77.7%), 
while 36 (20%) came from Andhra Pradesh. The state wise distribution of the study participants 
from south India is shown in Table 4  
 
 
The mean age of the study participants were 33.28 (SD= 7.28 yrs, Range 21-52 yrs).  
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Table 3: Sources (ID clinic) of the prospective study participants (n=198) 
 
 
Source 
 
Number 
 
Percentage % 
 
ID Clinic CHAD 
 
28 
 
14.1 
 
ID Clinic CMCH 
 
170 
 
85.8 
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Figure 5: Regional Distribution of Study Participants (n=198) 
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Table 4: The state wise distribution of the prospective study participants from south India 
(n=180) 
 
States No. of Patients Percentage 
  Tamil Nadu         140         77.7 
 Andhra Pradesh          36       20.0 
Karnataka            1        0.55 
Kerala            1        0.55 
Pondicherry            1        0.55 
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Table 5 shows the age wise distribution of 198 HIV seropositive women in the study.  It shows 
that predominance of two age groups, women of 30-49 years of age which accounted for 98 
(49.49%), followed by 20-29 years of age that constitutes 69 (34.84%) of the 198 cases. Among 
the 198 women majority 180 (91%) were house wives while the remaining 18 (9%) were 
working women. This data is shown in Figure 6.   
Fifty five women among the study participants were symptomatic. Twenty seven among these 55 
women presented with vaginal discharge while the remaining 28 were found to have discharge 
during per vaginal examination. Figure 7 shows the distribution of the study participants based 
on their symptoms.  
5.3.2 The Trichomonas vaginalis positivity among the prospectively collected samples from 
HIV infected women by three different assays  
Among the 198 samples tested by wet mount only 1 (0.5%) were found to be positive for 
Trichomonas vaginalis trophozoite. Figure 8 shows the representative wet preparation showing 
Trichomonas vaginalis trophozoite.  A methylene blue stained preparation of the Trichomonas 
vaginalis trophozoite in a wet preparation from a culture positive HIV infected woman is shown 
in Figure 9  
 
Six (3%) of the 198 samples showed positivity in modified Diamond’s culture medium. Four of 
these samples showed positivity in the broth culture by 24 hours.  The other two showed  
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Table 5: Distribution of the prospective study participant in the different age category 
(n=198)  
 
 
Age in years 
 
No. of HIV infected women 
 
Percentage 
 
20-29 
 
69 
 
34.84 
 
30-39 
 
98 
 
49.49 
 
40-49 
 
22 
 
11.11 
 
50-59 
 
 
9 
 
4.54 
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Fig 6: The distribution of the study participants based on their occupation (n=198) 
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Fig 7: The distribution of the study participants based on their symptoms (n=198) 
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Fig 8: Trophozoites of Trichomonas vaginalis in wet mount preparation   
 
Trophozoite 
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Fig 9: Methylene blue stained preparation trophozoite of Trichomonas vaginalis in a 
culture positive sample 
 
 
 
 
Trophozoite 
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positivity within 48 hours. Among these only one was positive by wet mount preparation as well 
and that sample showed positivity in culture by 24 hours.  A photograph of the un-inoculated and 
inoculated modified Diamond’s media is shown in figure 10 
Ten (5.03%) samples were found to be positive by the non- nested PCR assay. All the 6 culture 
positive samples were also positive by the PCR.  One of the culture positive samples, which were 
also positive by wet mount preparation, was negative by the PCR when first tested. However, 
PCR was repeated with 1/10 and 1/100 diluted DNA input, the 1/100 diluted sample showed a 
positive result. This negative PCR result in the undiluted sample and the 1/10 diluted sample 
may be due to the template excess. A gel picture showing the PCR in different dilutions for the 
sample which was wet mount and culture positive is shown in Figure 11.  
The performance of the culture and the non nested PCR assay was compared using the Kappa 
coefficient analysis.  There was a significant observed agreement of 98% (kappa coefficient of 
0.74) between the PCR and culture (Z value 10.79, p value <0.001). The agreement of the PCR 
assay findings and culture results in the prospectively collected samples are shown in Table 6.   
There were 6 culture negative samples which were positive by PCR when tested for the first 
time. On adjudication of these 6 discrepant samples by repeating the PCR assay, 4 culture 
negative but PCR positive samples were repeatedly positive.  Any samples which showed 
positivity twice or more were taken as positive for the analysis.   The results of the PCR assays 
run in triplicate for the 6 discrepant samples in culture and PCR with the final results are shown 
in Table 7. 
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Fig10: A typical photograph of the un-inoculated and inoculated modified Diamond’s 
media  
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Figure 11: A gel picture showing the PCR positivity in different dilutions for the sample 
showing wet mount and culture positive.  
 
 
Lane 1    Molecular Weight marker 
Lane 2    concentrated sample 
Lane 3    1/10 dilution of the concentrate 
Lane 4    1/100 dilution of the concentrate 
Lane 5    Negative control 
Lane 6    Positive control
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Table 6: Agreement of PCR assay findings and culture results in the prospectively collected 
samples  
 
T.Vaginalis Culture status  
POSITIVE NEGATIVE 
 
POSITIVE 
6* 4  
PCR  
NEGATIVE 
0 188 
 
* One of the culture and wet mount positive sample amplified only after testing a 1/100 diluted 
DNA (template excess) 
 
Observed agreement     0.98 
Chance agreement    0.92 
Kappa      0.74 
SD error of Kappa    0.0686 
Z      10.79 
P value     0.001 
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Table 7: Results of the adjudication of discrepant samples (n=6) by repeat PCR testing 
 
Patient ID Culture PCR1 PCR2 PCR 3 Final 
Result 
TV 73 Negative positive Negative Positive Positive 
TV 76 Negative Positive Positive Positive Positive 
TV 214 Negative Positive Negative Positive Positive 
TV 230 Negative positive Negative Negative Negative 
TV 263 Negative positive Negative Negative Negative 
TV 306 Negative positive Positive Positive Positive 
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Proportion of samples positive (5.5%) by any one tests in symptomatic (n=55) individuals were 
higher (4.9%) than asymptomatic individuals (n=143). However, this difference was not 
significant (p = < 0.05). These data is shown in Table 8.  
Considering culture as gold standard the sensitivity of the wet mount and the PCR were 
analyzed. The sensitivity of the wet mount was only 16.6% with 100% specificity. This accuracy 
indices of the wet mount compared to the broth culture is shown in Table 9.   
The non nested PCR assay had a sensitivity of 100% and a specificity of 98% when compared to 
the broth culture. The accuracy indices calculated for the PCR based on the culture is shown in 
Table 10.  
 The frequency of Trichomonas vaginalis by PCR in the HIV infected woman in our population 
was 5.05%. The percentage positivity for the different assays used in the study is shown in Table 
11.  The profile of the 10 Trichomonas vaginalis positive women by any one test with other 
available relevant tests is shown in Table 12.  
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 Table 8: Laboratory findings in HIV infected women who presented with vaginal 
discharge or no abnormality  
 
 No. of patients Wet mount 
Positive 
Culture 
Positive 
PCR 
Positive  
Any one test 
Positive 
 
Symptomatic 
 
55 (27.7%) 
 
0(0%) 
 
2 (3.6%) 
 
3 (5.5%) 
 
3 (5.5%) 
 
Asymptomatic 
 
 
143 (72.22%) 
 
1 (0.6%) 
 
4 (2.7%) 
 
7 (4.9%) 
 
7(4.9%) 
 
Total 
 
198 
 
1 
 
6 
 
10 
 
10 
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Table 9: The accuracy indices calculated for the wet mount preparation based on the 
culture results  
 
T.vaginalis Culture status   
POSITIVE NEGATIVE 
POSITIVE 1 0 T.vaginalis  
WET MOUNT 
NEGATIVE 5 192 
 
SENSITIVITY     16.7% (0.9 – 63.5) # 
SPECIFICITY     100% (97.6 – 100) 
POSTIVE PREDICTIVE VALUE              100% (5.5 – 100) 
NEGATIVE PREDICTIVE VALUE         97.5% (93.9 – 99.1) 
 
 # Figures in parentheses are the 95 % confidence interval values 
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Table 10: The accuracy indices calculated for the PCR based on the culture findings 
 
T.vaginalis Culture status   
POSITIVE NEGATIVE 
POSITIVE 6* 4 T.vaginalis  
PCR ASSAY 
NEGATIVE 0 188 
 
* One of the culture and wet mount positive sample amplified only after testing a 1/100 diluted 
DNA (template excess) 
 
SENSITIVITY     100%       (51.7 – 100) # 
SPECIFICITY     97.9%      (94.4 – 99.3) 
POSTIVE PREDICTIVE VALUE              60%      (27.4 – 86.3) 
NEGATIVE PREDICTIVE VALUE         100%      (97.5 – 100) 
 
# Figures in parentheses are the 95 % confidence interval values 
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Table 11: Laboratory findings in the samples obtained from HIV infected women  
 
 
Type of tests 
 
No of positives 
 
Percentage 
Wet mount 1 0.5 
Culture 6 3.0 
PCR 10 5.05 
Both  wet mount and   culture 
positive 
1 0.5 
Both culture  and PCR positive 6 3.0 
All three test positive 
 
1 
 
0.5 
 
Any one test  positive 10 5.05 
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Table 12:  The profile of the ten Trichomonas vaginalis positive (by any one test) 
individuals with other available relevant test results 
Sl. 
No 
Patient 
ID 
Age  
(years) 
Area Symptom WP Culture PCR HbsAg VDRL HCV 
1 TV24 30 TN asymptomatic + + + - - - 
2 TV 73 35 TN asymptomatic - - + NA NA Neg 
3 TV76 33 AP asymptomatic - - + Neg NR NA 
4 TV200 33 TN Symptomatic - + + Neg NR Neg 
5 TV204 25 TN asymptomatic - + + Neg NR Neg 
6 TV214 27 TN asymptomatic - - + Neg NR Neg 
7 TV232 48 TN asymptomatic - + + Neg NR Neg 
8 TV258 25 AP asymptomatic - + + Neg NR Neg 
9 TV286 28 TN Symptomatic - + + Neg NR Neg 
10 TV306 30 TN Symptomatic - - + Neg NR Neg 
 
#NA – not available  
NR- Non Reactive 
Neg- Negative 
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6.  DISCUSSION 
Trichomoniasis caused by Trichomonas vaginalis is the common non viral sexually transmitted 
disease among humans (111). The annual incidence of this disease globally as estimated by 
WHO is 170 million (114). In this study reported here a PCR targeting the adhesion and Beta 
tubulin genes of T. vaginalis was standardized for the detection of the parasite in vaginal swab 
samples.  The usability of this PCR was compared with culture and wet preparation of 
prospectively collected vaginal swab samples from HIV infected women.   
There are number of tests that can be used for the diagnosis of Trichomoniasis. These include 
vaginal wet preparation, vaginal swab culture and vaginal swab PCR. Apart from vaginal swabs, 
urine can be also used as a specimen for the diagnosis by any one of the mentioned tests (54, 91). 
In a randomized community based study done in Kenya, among 675 women using self collected 
vaginal swabs and centrifuged urine samples, T.vaginalis was detected in 17.9% of the women 
using vaginal swab samples. However, the positivity was only 3.4% by using centrifuged urine 
as sample. The culture of centrifuged urine showed a sensitivity of 17% with a specificity of 
99.6% (71).  In another study done at the University of Alabama in Birmingham, among 190 
women attending a STD clinic, compared the usability of vaginal swabs and urine specimen for 
the detection of T.vaginalis using visualized from any wet preparation or culture as gold 
standard.  Compared to the gold standard, vaginal swab culture showed a sensitivity of 94.3% 
while the sensitivity of urine sample was 60.4% (54).  
Thus in both the above studies, urine specimen used for diagnosis of Trichomoniasis both in 
community as well as hospital setting showed a poor sensitivity.  Therefore in our study vaginal 
swab was used for the detection of T.vaginalis.by the three methods carried out. 
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The most commonly used test for the diagnosis of T. vaginalis is the wet preparation. The 
sensitivity of wet preparation as compared to culture varies from 30% – 58% (62, 91). The 
sensitivity of wet preparation shown to be less in asymptomatic individuals compared to 
symptomatic individuals (92). The wet preparation has a number of limitations like the 
sensitivity is highly dependent on the expertise of the individual taking the reading, prompt 
transport of the specimen and processing of the sample required by the laboratory before the 
organism loses its motility or lyses (62). One another issue is that the size of the trichomonad is 
approximately the same as that of a lymphocyte or a small neutrophil and could be confused with 
this. More over when the organism is not motile, trichomonads can be difficult to differentiate 
from the nucleus of a vaginal epithelial cell.  Motility of T. vaginalis is very much dependent on 
the temperature at which the specimen is stored. At room temperature the organism will remain 
alive for more than 6 hours but as the time passes the organism’s motility becomes significantly 
attenuated.(31)   However, there are several advantages as well like the test is rapid and most 
cost effective. Though the sensitivity of the wet preparation can be increased by making the 
preparation at the site of collection of sample it is still sub-optimal when compared to other 
techniques (31). In our study the sensitivity of wet mount was only 16.7% when compared to 
culture even after carrying out the examination of the wet preparation at the site of the sample 
collection by the technicians in both the ID clinics chosen for the study. Based on the wet mount 
preparation the frequency of T.vaginalis in our study population was only 0.5%.  The positive 
predictive value was 100% with 95% CI of 5.5 to 100.   
In a study conducted in Birmingham, Alabama University, among 190 women attending the STD 
clinic, the prevalence of trichomoniasis was 28%. Wet preparation was done on vaginal swabs 
and the sensitivity of wet mount was 58.5%.as compared to culture.  Sood et al (2007) has 
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compared the wet preparation and In pouch culture with samples from women presenting with 
genitourinary symptoms attending a primary health center clinic in Haryana, India. Compared to 
the culture the sensitivity of the wet preparation was 55%. As reported previously, compared to 
culture the sensitivity of the wet preparation is quite poor in our study as well.  One of the 
disadvantages with this low sensitivity of detection of Trichomonas vaginalis among HIV 
infected women by the routine wet preparation is that many infected women may not receive 
appropriate treatment otherwise with metronidazole.  This will lead to complications in infected 
individuals, transmission to sexual partners, and also can even increase the transmission of HIV.   
These findings suggest the need for a more accurate diagnostic method for trichomoniasis.  
Broth culture technique using Diamond’s medium is considered as the ‘gold standard’ for the 
diagnosis of Trichomoniasis. The minimum inoculum size required for a positive result is about 
102 organisms/ ml and the growth of the organism is easy to interpret (100).  While the number 
of organism required for a wet preparation is about 104 organism/ml (31, 93).  The standard 
culture broth used for culture of T. vaginalis is the Diamond's TYI medium in glass tubes 
(25,31). The sensitivity varies from 85-95% (28, 62, 98, 100). However, this too has its own 
limitations. It requires special media, results are available within 2-7 days and a microbiologist is 
required for the test (86). Another disadvantage is the contamination with bacteria of vaginal 
flora even with broth cultures spiked with antibiotics. Normally Diamond’s media uses horse 
serum for the growth of the organism.  However, the media we used for culture contained sheep 
sera instead of horse sera.  This modification hasn’t changed the sensitivity of the medium in our 
laboratory (29, 67). We also used Diamond’s medium with penicillin and streptomycin but 
without amphotericin B. There are several studies which demonstrated that T. vaginalis can be 
cultivated successfully without amphotericin B (117). However, in our study few of the samples 
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showed growth of Candida within in 24 hours of incubation and by 48 hours there was over 
growth of candida. This may have prevented the appreciation of the typical motility of 
T.vaginalis. Our experience form this study suggest that it would be better to add amphotericin B 
or any other antifungal agents in the Diamond’s media for the culture of Trichomonas vaginalis. 
There is also a modified and simplified culture system commercially available, the In Pouch 
system (Biomed Diagnostics, USA). In this culture system the specimen is put into a two-
chambered bag, allowing sampling for immediate wet mount microscopy and incubation for 
culture (15). Sood et al (2007) has found this In Pouch Trichomonas vaginalis culture system is a 
simple, cost-effective and a sensitive method for diagnosing T. vaginalis (93). Although the 
combination of culture and wet mount examination remains the standard approach for detecting 
T. vaginalis in patient samples there is no gold standard for confirmation (49). There are several 
studies which looked at the usability of polymerase chain reaction (PCR) for the detection T. 
vaginalis. PCR was shown to be more sensitive (80-100%) (54, 86, 90, 112) than culture and wet 
preparation.  
A number of primers have been described for PCR vaginal swab as the specimen (54, 61, 62, 
80). In a study done in STD clinic at Seattle among symptomatic and asymptomatic women, 
primer designed for the adhesisn gene of trichomonas vaginalis (TVA5/TVA6) was able to 
detect all the 24 isolates as compared to all the other three sets of primers namely target sequence 
T17rp (TR7/8), target sequence T9p (TR5/6 ) and ferreoxdine gene (FE1/2). In our study also we 
used TVA5/TVA6 primer set. This primer set amplifies a 102bp genomic sequence termed as 
A6p. This area is a much conserved segment of the adhesisn gene and hence the PCR using 
primer set of TVA5/TVA6 was proved to be highly selective for a wide range of T.vaginalis 
isolates (86).  
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In an another study conducted among the female sex workers attending the STD clinic Institute 
of Tropical Medicine, Belgium, where three sets of primers were evaluated using vaginal swab 
as sample.  The   primer sets used were, TVA5/TVA6, one amplifying a portion of beta tubulin 
gene (BTUB9/2) and 312bp sequence to amplify repetitive DNA specific to T.vaginalis 
(TVK3/7). The sensitivity and specificity of the PCR with primer set BTUB9/2 was 77.1 and 
96%, with TVA5/TVA6 it was 64% and 99.7% respectively. The sensitivity and the specificity 
with the TVK3/7 primer set was 88% and 97% respectively. According to this study, TVA5/6 
was highly specific, were as TVK3/7 showed a high sensitivity (104). A study done among the 
women attending the epidemiology clinic in Maryland again on vaginal swabs showed a 
sensitivity of 97% and specificity of 98% with the primer set of BTUB9/2 (62). 
Another study done in Netherlands, again with vaginal swabs as sample, and the primer set 
TVK3/7 detected 87% of the culture positive. These PCR assay also detected 12 cases by PCR 
alone.  TVA5/6 being highly specific for trichomonas vaginalis was used for the confirmation of 
these positives, and 9 cases were confirmed positive. All the above mentioned primers showed 
different sensitivity and specificity in different studies. This variation may be due to the variation 
of the strain circulating in any one region (90). 
In the study reported here two sets of primers TVA5/6 and BTUB9/2 were selected based on 
their sensitivity and specificity. The primer TAV5/6 which is highly specific to detect the 
adhesion gene was chosen along with another primer BTUB9/2 to detect beta tubulin gene also 
shown to have very high sensitivity and specificity. While standardization the results with primer 
set of TAV5/TAV6 were found to be better in detecting different dilution of the broth culture 
when compared to the BTUB2 primers. Therefore it was decided to use the primer set of 
TVA5/TVA6 for the PCR amplification.  
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However, the PCR with TVA5/TVA6 using on the positive and negative cultures, with 
commercial regents using recombinant Taq polymerase (Fermentas Life Sciences, USA), it 
showed a sensitivity of (43.3%) compared to culture positive samples.  The specificity of this 
primer set was found to be good (98%). The specificity depends on the annealing temperature, 
with higher temperatures favoring higher specificity.  In this study reported we also used the 
touchdown protocol of PCR to increase the specificity of the assay. This favored the 
amplification of targeted copies of DNA amplified during early cycles at higher annealing 
temperatures and eliminating spurious products.  Since the earlier studies showed a sensitivity of 
> 90% for this primer set comparatively far better than ours we decided to change the PCR 
reagents used.  
In order to improve the sensitivity of the PCR assay we further used HotStarTaq Master Mix 
reagent (Qiagen, Hilden, Germany) for doing the assay, using the same set of primers. This 
Master Mix contains HotStarTaq DNA Polymerase. HotStarTaq DNA polymerase has been used 
to do touchdown enzyme time PCR for C. trachomatis, C. psittaci and C. pneumoniae using 16-
Sand 16-s 13-s Spacer r-RNA gene. The sensitivities shown by this PCR was very similar to that 
shown by AmpliTaq Gold suggesting that HotStarTaq ampliTaq Gold can be used as an 
alternative (61).  Like the AmpliTaq Gold, the HotStarTaq also not active until heated to 95°C. 
The use of this enzyme was also able to avoid erroneous amplification of DNA products due to 
nonspecific annealing of primers at lower temperatures. 
 In our study, the use of HotStarTaq Master Mix in place of conventional PCR reagents 
(recombinant DNA Taq Polymerase) showed a marked improvement in the sensitivity of the 
assay. The sensitivity improved from 43.3% to 86.6% compared with culture i.e. there was an 
improvement in sensitivity by 100% which is quite significant. Specificity of the TVA5/TVA6 
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remained the same with this reagent.  These four culture positive samples were tested repeatedly 
and found negative. In order to rule out any template excess that may inhibit the PCR, extracted 
DNA from these samples were retested in dilution of /10 and 1/100. However, the result was 
same.  In this study the PCR with TVA5/TVA6 primer set failed to detect 4 culture positive 
samples. Reason could be attributed to the sensitivity of the primer used or those strains may be a 
variant that prevented the primers annealing to the DNA.  It is possible that the use of another 
primer set like BTUB9/2 to detect another region of the T.vaginalis genome could have detected 
these culture positives. There are several studies for other organisms which have demonstrated 
that detection of more than one region by PCR can increase the sensitivity of the assay (62).    
In the study reported here we collected the samples i.e vaginal swabs in 1 ml sterile normal 
saline squeezed out the swab and stored it till extraction at -20˚C.  Pillay et al (2007) has also 
shown the successful amplification of DNA from vaginal washes with normal saline (80).  A 
total of 10 samples were found positive by the PCR assay used. In our study all the 6 culture 
positive samples were also positive by the PCR assay.  However, one of the culture positive 
samples became positive only after repeating the PCR with a 1/100 diluted DNA input. This 
particular sample was also positive by the direct wet mount preparation. This indicated a larger 
number of parasites in the original sample. Hence, the lack of amplification in the undiluted and 
1/10 diluted sample may be due to template DNA excess. The template excess may cause 
chelation of Mgcl2 added to suboptimal level for the results for the PCR reactions. 
 Six culture negative samples were found to be positive by PCR during the initial run. In order to 
confirm the true results all the 6 samples which showed discrepant results were repeat tested in 
duplicate by the PCR assay. A concordant result of two or more times in the triplicate run was 
considered as the final result. Four of the 6 culture negative samples were repeatedly positive in 
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the PCR assay and those samples were considered as true positive as the primer set TVA5/TVA6 
was highly specific. However, the ideal way to confirm the true positivity is to sequence the 
product and see it matches with the expected nucleotide sequence or carry out another PCR for 
the amplification of a different region.  Compared to the culture the PCR assay used in our study 
was found to have significant observed agreement (Z =10.49, p < 0.001) with a Kappa 
coefficient 0.74.  Moreover the assay was able to detect 4 additional samples than culture.  
As for the quality checkup of the prepared media, as recommended by the National committee 
for clinical laboratory Standards guidelines, 5% of media in each batch must be inoculated with 
reference strain ATCC30001 of T.vaginalis. For this study we could not procure the reference 
strain of T.vaginalis due to the inability to maintain the strains in our laboratory.  Hence, for the 
media quality checking we inoculated three tubes of media per batch (each batch 15 tubes) with 
the positive culture we obtained with the previous batch of media and checked for growth by 
preparing wet mounts for 7 days.  However, we had three batches of media for which we could 
not check the quality as the previous batches did not have any positive samples and laboratory 
did not have any facility for storage in a viable form of the previous positive strains.  There is a 
possibility that we would have missed some positive samples due to this reason.  We had picked 
up 4 samples as positive by PCR, which were negative by culture. The quality of the media in the 
batches which picked up these positives had been checked and was found to be satisfactory. This 
makes us believe that the quality of those three batches of media was also satisfactory.  
The prevalence of T.vaginalis varies in different population. This depends on their social and 
demographic profile. A study conducted by Mathai et.al (1998) among 300 women coming for 
antenatal check up in a tertiary care set up in South India showed that 6% of these women had 
T.vaginalis infection. Among the positive women only 3(7%) were symptomatic (67).  In another 
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study among 232 women attending antenatal clinic at Denver, 14.66% were detected to have 
T.vaginalis infection (22).  In  a multicentre study by Uneke et al (2005) among 502 women 
attending antenatal clinic in South–Eastern Nigeria in the year 2005 , the prevalence of 
T.vaginalis was shown as 6.9%.The prevalence was seen highest (3.7%) among 20-25yrs and 
lowest (1.9%) among 26-30yrs of age (106). 
 
In a community based cross-sectional study from a rural area done by Prasad et al (2005) among 
451 married women between 16-22 yrs of age, in Tamil Nadu, 13% of women had T. vaginalis 
infection. Among the positives 70 % were asymptomatic and 30% were symptomatic (83). A 
multicentric community based study of sexually transmitted disease in Surat, India among 102 
women showed 34.3% prevalence of T.vaginalis.  It was also found that among 16 women who 
had symptoms 75% women had T. vaginalis infection while among the remaining asymptomatic 
women 26.6% had trichomoniasis (17). Study done by Bhatt et al (1997) in the gynecology out-
patient clinic of a tertiary care set up in Mumbai, India among 500 women with symptoms, 
infertility or pregnancy as well as asymptomatic women showed that 85 (17%) of these women  
had Trichomoniasis. Among whom 61 women were symptomatic, 18 were pregnant and 6 
women were infertile (13).  Retrospective analysis trends of STD in clinics at Chengalpattu, 
Tamil Nadu over a period of 7yrs (1988-1994) reported a total attendance of 4549 patients with 
3621 (79.6%) males and 928 (20.4%) females. Among the females 17.2% were detected to have 
Trichomonas vaginalis infection.(49)  Desai et al. (2003) had investigated 124 sex workers in 
whom the prevalence of syphilis, gonorrhea, chlamydial infection and trichomoniasis were 
looked at. All these women belonged to the ages of 16-50 yrs, and 58.5% of these were 
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asymptomatic. Among the symptomatic 12.7% women had vaginal discharge and 14.4% women 
were confirmed to have trichomoniasis (20). 
 
 In a case controlled study reported from Congo, among the HIV infected and uninfected mothers 
18.6% of HIV infected women and 10.2% of HIV uninfected women were shown to have T. 
vaginalis infection (101). In another study done in USA among the HIV infected individuals 
(228 seropositive men and 340 seropositive women) 9% had trichomoniasis, 6% gonorrhea, 4% 
chlamydia and 22% other STI’s. The mean age among the sexually active women with STI’s was 
reported as 38.3 and about 17% of these women had symptoms of vaginal discharge (42).   In 
another study in a STD clinic at New York among 1285 HIV infected individuals and HIV non 
infected women but with high risk behavior 12% and 10% of frequency reported for 
trichomoniasis respectively (19). Compared to these reports the frequency of T.vaginalis in HIV 
seropositive Nigerian women were found to be very high (99). T.vaginalis infection was highly 
prevalent (32.6%) in women in age group of 26yrs – 30yrs, and least (18.8%) prevalent among 
women in age group of 20yrs -25yrs and more than 40yrs (106).  Another report from Nigeria 
demonstrated the prevalence of T. vaginalis in different age groups and were as follows, 30% in 
5-15yrs, 46.6% between 16-21 yrs, 41.2% between 28-33 yrs, 28.9% between 34-39 yrs, 
27.7%between 22-27yrs about 10% in 40-51yrs and 16-21yrs. T.vaginalis infection was not seen 
in 52-57 yrs age group individuals (76). 
In our study 204 women were recruited. These women were chosen on their first visit to either of 
the two infectious disease clinic selected for the study.  A good number of patients were either 
referred from other hospitals or from other clinics in this hospital, to the infectious disease clinic. 
Two such patients, who were detected to be HIV seropositive in a center elsewhere, were 
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confirmed negative on repeating the HIV test in our hospital. These two women were excluded 
from the study.  Another four patients who though HIV positive could not be enrolled in the 
study because, for two of them saline swabs  for PCR were not taken by the clinician, while there 
was a spillage of the culture media with the samples taken in 2 cases during transport.  Hence, 
only 198 HIV seropositive women were included in the study and all three tests were done on 
vaginal swabs taken from them.  Geographically, there was an unequal representation of patients 
from both Northern and Southern part of India with predominance from South India as the 
hospital is situated in the south. 
Out of 198 HIV positive females included in our study, there were only 6 patients (3%) who 
were positive for T. vaginalis infection by culture. Most of these patients were in the age group 
of 25-33 years. This is quite comparable with the age distribution in the above studies .The age 
group between 15-45 yrs is considered as the reproductive age and also during this period 
females are sexually active. All the women included in our study were married.   Majority (73%) 
of our study participants were asymptomatic women.   The proportion of women positive for 
Trichomonas vaginalis by any one test in our population was higher among the symptomatic 
individuals (5.5%) compared to asymptomatic women (4.9%) but the difference was not 
statistically insignificant (p > 0.05). Our results were in similar to studies done in Tamil Nadu, 
Mumbai and Surat where higher percentage of T. vaginalis infection was seen among the 
symptomatic women (17, 20, 67).  Four (67%) out of 6 women tested positive by culture and 
seven (70%) out of 10 women tested positive by PCR assay compared were asymptomatic.  This 
result is very similar to the study by Mathai et al (1998) from the same institution where only 3 
(17%) of 18 women found positive for T. vaginalis in antenatal clinic were symptomatic. It is 
possible that women who came to our hospital who had symptoms suggesting T.vaginalis 
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infection would have been treated elsewhere and were negative when tested here. Moreover as 
the patients who had tested positive for T. vaginalis were mostly asymptomatic would not have 
felt the need to seek treatment, and were accidently detected positive on routine checkup.  As 
discussed earlier the presence of one STI can cause transmission of other STI’s, moreover an 
asymptomatic individual may not feel the need for investigation and treatment, an efficient and 
sensitive method of screening such patients is needed. 
Our study has shown the frequency of trichomoniasis in HIV infected women as 5.05 % with 
PCR or any one assay positive. We expected a higher frequency of Trichomonas vaginalis 
among the HIV infected women. However, this frequency is almost similar (6%) to the 
frequency seen among women in antenatal clinic but lower (13%) than reported from a rural 
community and STI clinic attendees of neighboring district of Tamil Nadu  (49, 67, 83). The 
possible reason for this low prevalence could be attributed to, the selection of patients for the 
study. Since the study setups were in tertiary care centre and relatively expensive, only patients 
who can afford the management may come to the hospital. Another reason may be the use of 
metronidazole prescribed by the general physicians and later coming to a tertiary care center like 
our hospital.  The study done in high risk groups with other sexually transmitted infections 
would have possibly shown a different picture.  
In conclusion our study clearly showed that the PCR assay using the TAV5/TAV6 primer set is a 
highly sensitive method for the detection of Trichomonas vaginalis compared to the culture. The 
frequency of the infection in HIV infected woman was 5.05% by any one positive test. It is 
important to screen the high risk group individuals like HIV positive women for Trichomonas 
vaginalis routinely with highly sensitive techniques like PCR as most of the individuals are 
asymptomatic and may not receive appropriate treatment otherwise with metronidazole.  Lack of 
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timely management of the infection may lead to complications in infected individuals and also 
can increase the transmission of HIV to partners. Testing algorithm should be wet mount and if 
negative test by PCR as it is rapid compared to culture which takes 7 days. 
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7.  SUMMARY AND CONCLUSION 
Trichomoniasis caused by the protozoan parasite Trichomonas vaginalis is the most common 
non-viral sexually transmitted infection. In this study reported here a PCR targeting the adhesion 
and Beta tubulin genes of T. vaginalis was standardized for the detection of the parasite in 
vaginal swab samples.  The usability of this PCR was compared with culture and wet preparation 
of prospectively collected vaginal swab samples from HIV infected women attending infectious 
disease clinics.   
 In the standardization of PCR the primer set TAV5/TAV6 targeting the adhesin gene of 
Trichomonas vaginalis was found to have better performance in experiments on lower 
limit of detection than the BTUB9/2 primer set targeting the Beta tubulin  
 The HotStar Taq Master Mix (Quaigen, Hilden, Germany) for the PCR assay has 
significantly improved the sensitivity of the PCR from 43.3% to 86.7% i.e., an 100% 
increase compared to the regular Taq polymerase (Fermentas, Life Sciences, Canada, 
USA). The specificity (97.6%) of the PCR assay was same with both the reagents used.  
 Majority of the participants (91%) in the prospective study were from South India. 
Among the 198 study participants 140 were from state of Tamil Nadu. 
 There were 55 symptomatic and 143 symptomatic participants. 
 Mean age of the study participants was 33.6 yrs (21-52 yrs) with 84% of the individuals 
in the sexually active age group of 20-39.   
 Majority of the study patients were housewives 180(91%) 
99 
 
 Among 198 HIV seropositive women only 1 (0.05%) tested positive for Trichomonas 
vaginalis by wet mount preparation. The sensitivity of wet mount as compared to culture 
was only 16.7%. 
 Six (3%) of the 198 samples showed positivity in modified Diamond’s culture medium. 
 Ten (5.05%) samples were found to be positive by the non nested PCR assay. All the 
culture positive samples were detected by the PCR assay. However, one sample which 
was positive by culture and wet mount preparation showed positivity in PCR with 1/100 
diluted DNA input. The negative PCR result in the undiluted and the 1/10 diluted sample 
may be due to the template excess.  
 Compared to broth culture, the non nested PCR assay showed 100% sensitivity in the 
prospective study.  Moreover the assay was able to detect 4 additional samples than 
culture.   
 There was a significant observed agreement of 98% (kappa coefficient of 0.74) between 
the PCR and culture (Z value 10.79, p value <0.001) in the prospective study.  
 The proportion of women positive for Trichomonas vaginalis by any one test in our 
population was higher among the symptomatic individuals (5.5%) compared to 
asymptomatic women (4.9%). This difference was not statistically significant >0.005. 
Four (66.6%) out of 6 women tested positive by culture and 7 (70%) out of 10 women 
tested positive by PCR assay were asymptomatic. 
 The frequency of trichomoniasis in the HIV infected women of our study population was 
5.05 % by any one test. 
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 The PCR assay used in this study showed good sensitivity compared to culture in 
Diamond’s media in the prospective study. Moreover the assay also detected 4 additional 
culture negative samples.  The assay is very rapid compared to culture. 
 The testing algorithm should be wet mount which if negative, PCR assay should be done 
since it is rapid and takes a less duration. 
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PROFORMA  
 
Study  No: 
Name of the Patient: 
Age: 
Hospital Number: 
Residence: 
Occupation: 
Symptoms: 
 
Current Clinical Diagnosis: 
Treatment History: 
 
Test to rule out other infection: HIV  HCV  HbSAg  VDRL  
 
Date of Sample collection:     Signature of 
physician/Researcher 
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Serial 
no 
Code 
no 
Sample 
no 
Hospital 
no Name of Patients wet mount Culture PCR 1 
1 HP101 TV258 132526 Parameshwari POSITIVE POSITIVE NEGATIVE
2 HP102 TV270 431497 Jeyakodi NEGATIVE NEGATIVE POSITIVE 
3 HP103 TV267 110668 Kalyani NEGATIVE NEGATIVE NEGATIVE
4 HP104 TV395 103192 Jothylakshmmi NEGATIVE NEGATIVE NEGATIVE
5 HP105 TV245 191152 Sumathy NEGATIVE NEGATIVE NEGATIVE
6 HP106 TV181 212504
Nadhiya 
Manoharan POSITIVE POSITIVE NEGATIVE
7 HP107 TV304 325662 Adilakshmi POSITIVE POSITIVE NEGATIVE
8 HP108 TV650 357315 Thilagavathy POSITIVE POSITIVE NEGATIVE
9 HP109 TV333 473677 Shylaja POSITIVE POSITIVE POSITIVE 
10 HP110 TV6 404986 Jothy NEGATIVE NEGATIVE NEGATIVE
11 HP111 TV341 461274 Thanjammal NEGATIVE NEGATIVE NEGATIVE
12 HP112 TV335 440078 Sudha POSITIVE POSITIVE POSITIVE 
13 HP113 TV306 333524 Amudha NEGATIVE NEGATIVE NEGATIVE
14 HP114 TV303 325776 Anabarasi POSITIVE POSITIVE POSITIVE 
15 HP115 TV302 325444 Lakshmi NEGATIVE NEGATIVE NEGATIVE
16 HP116 TV550 263071 Meena POSITIVE POSITIVE POSITIVE 
17 HP117 TV537 16169 Jayanthi NEGATIVE NEGATIVE NEGATIVE
18 HP118 TV450 640704 Girija NEGATIVE POSITIVE NEGATIVE
19 HP119 TV293 132156 Manjula POSITIVE POSITIVE NEGATIVE
20 HP120 TV301 325537 Deepa NEGATIVE NEGATIVE NEGATIVE
21 HP121 TV281 104570 Elyarani POSITIVE POSITIVE NEGATIVE
22 HP122 TV278 104950 Thamaramani NEGATIVE NEGATIVE NEGATIVE
23 HP123 TV613 492940 Shyamalamani NEGATIVE NEGATIVE NEGATIVE
24 HP124 TV320 324955 Kalaiselvi NEGATIVE NEGATIVE NEGATIVE
25 HP125 TV183 161282
Pushpa 
Ravizuman NEGATIVE POSITIVE POSITIVE 
26 HP126 TV318 325054 Lakshmi NEGATIVE NEGATIVE POSITIVE 
27 HP128 TV232 118830 Chellatalini NEGATIVE POSITIVE POSITIVE 
28 HP129 TV311 323478 Selvi NEGATIVE NEGATIVE NEGATIVE
29 HP130 TV276 104968 Remya POSITIVE POSITIVE POSITIVE 
30 HP131 TV336 432683 Poonkodi NEGATIVE NEGATIVE NEGATIVE
31 HP133 TV418 534468 Jayasudha NEGATIVE NEGATIVE NEGATIVE
32 HP134 TV100 200907 Suthasumitra POSITIVE POSITIVE POSITIVE 
33 HP135 TV339 450561 Sumitha NEGATIVE NEGATIVE NEGATIVE
34 HP136 TV163 310936 Thenmozahi POSITIVE POSITIVE NEGATIVE
35 HP137 TV289 110929 Sumathy NEGATIVE NEGATIVE NEGATIVE
36 HP138 TV632 300902 Saridha NEGATIVE NEGATIVE NEGATIVE
37 HP139 TV291 104404 Pushplatha NEGATIVE NEGATIVE NEGATIVE
38 HP140 TV426 534594 Tamilarsi POSITIVE POSITIVE NEGATIVE
39 HP141 TV275 104968 Sasikala POSITIVE POSITIVE NEGATIVE
40 HP142 TV346 432704 Vijaylakshmi NEGATIVE NEGATIVE NEGATIVE
41 HP143 TV315 325114 Manjula NEGATIVE NEGATIVE NEGATIVE
42 HP144 TV529 373797 Lakshmi NEGATIVE NEGATIVE NEGATIVE
43 HP145 TV354 474152 Poongavanam POSITIVE POSITIVE POSITIVE 
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44 HP147 TV312 325108 Kokila NEGATIVE NEGATIVE NEGATIVE
45 HP148 TV499 352322 Poornima POSITIVE POSITIVE POSITIVE 
46 HP149 TV612 481471 Lakshmi NEGATIVE NEGATIVE NEGATIVE
47 HP150 TV531 461598 Manimeglai NEGATIVE NEGATIVE NEGATIVE
48 HP151 TV51 324859 Sugna POSITIVE POSITIVE POSITIVE 
49 HP152 TV337 473547 Sudha NEGATIVE NEGATIVE NEGATIVE
50 HP153 TV345 473680 Sythraiselvi NEGATIVE NEGATIVE NEGATIVE
51 HP155 TV530 102505 Poonkodi NEGATIVE NEGATIVE NEGATIVE
52 HP156 TV99 200907 Kamatachi POSITIVE POSITIVE POSITIVE 
53 HP157 TV321 333639 Priya NEGATIVE NEGATIVE NEGATIVE
54 HP158 TV609 482167 Chandra NEGATIVE NEGATIVE NEGATIVE
55 HP159 TV414 531390 Raleshwari NEGATIVE NEGATIVE NEGATIVE
56 HP161 TV390 811545 Nirmala NEGATIVE NEGATIVE NEGATIVE
57 HP163 TV1X 392523 Jamuna POSITIVE POSITIVE NEGATIVE
58 HP164 TV325 324297 Mahasundari NEGATIVE NEGATIVE NEGATIVE
59 HP165 TV460 599575 Kalaivani POSITIVE POSITIVE POSITIVE 
60 HP166 TV243 640429 Jeyamalini POSITIVE POSITIVE POSITIVE 
61 HP168 TV272 110972 Kalpana NEGATIVE NEGATIVE NEGATIVE
62 HP169 TV346 432702 Vijaylakshmi NEGATIVE NEGATIVE NEGATIVE
63 HP171 TV235 650459 Pushpa NEGATIVE NEGATIVE NEGATIVE
64 HP172 TV646 313492 Deepa NEGATIVE POSITIVE NEGATIVE
65 HP173 TV385 811398 Kalaiselvi POSITIVE POSITIVE NEGATIVE
66 HP174 TV502 352314 Chitra POSITIVE POSITIVE NEGATIVE
67 HP175 TV493 340200 Arputham POSITIVE POSITIVE NEGATIVE
68 HP176 TV252 132531 Akila NEGATIVE NEGATIVE NEGATIVE
69 HP177 TV305 333432 Devi NEGATIVE NEGATIVE NEGATIVE
70 HP178 TV541 751338 Venda NEGATIVE POSITIVE NEGATIVE
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Serial 
no 
Code 
no 
Sample 
no Hospital no Name of Patients Wet mount cuculture PCR2 
1 HP101 TV258 132526 Parameshwari POSITIVE POSITIVE POSITIVE 
2 HP102 TV270 431497 Jeyakodi NEGATIVE NEGATIVE NEGATIVE 
3 HP103 TV267 110668 Kalyani NEGATIVE NEGATIVE NEGATIVE 
4 HP104 TV395 103192 Jothylakshmmi NEGATIVE NEGATIVE NEGATIVE 
5 HP105 TV245 191152 Sumathy NEGATIVE NEGATIVE NEGATIVE 
6 HP106 TV181 212504
Nadhiya 
Manoharan POSITIVE POSITIVE POSITIVE 
7 HP107 TV304 325662 Adilakshmi POSITIVE POSITIVE POSITIVE 
8 HP108 TV650 357315 Thilagavathy POSITIVE POSITIVE POSITIVE 
9 HP109 TV333 473677 Shylaja POSITIVE POSITIVE POSITIVE 
10 HP110 TV6 404986 Jothy NEGATIVE NEGATIVE NEGATIVE 
11 HP111 TV341 461274 Thanjammal NEGATIVE NEGATIVE NEGATIVE 
12 HP112 TV335 440078 Sudha POSITIVE POSITIVE POSITIVE 
13 HP113 TV306 333524 Amudha NEGATIVE NEGATIVE NEGATIVE 
14 HP114 TV303 325776 Anabarasi POSITIVE POSITIVE POSITIVE 
15 HP115 TV302 325444 Lakshmi NEGATIVE NEGATIVE NEGATIVE 
16 HP116 TV550 263071 Meena POSITIVE POSITIVE POSITIVE 
17 HP117 TV537 16169 Jayanthi NEGATIVE NEGATIVE NEGATIVE 
18 HP118 TV450 640704 Girija NEGATIVE POSITIVE POSITIVE 
19 HP119 TV293 132156 Manjula POSITIVE POSITIVE NEGATIVE 
20 HP120 TV301 325537 Deepa NEGATIVE NEGATIVE NEGATIVE 
21 HP121 TV281 104570 Elyarani POSITIVE POSITIVE POSITIVE 
22 HP122 TV278 104950 Thamaramani NEGATIVE NEGATIVE NEGATIVE 
23 HP123 TV613 492940 Shyamalamani NEGATIVE NEGATIVE NEGATIVE 
24 HP124 TV320 324955 Kalaiselvi NEGATIVE NEGATIVE NEGATIVE 
25 HP125 TV183 161282
Pushpa 
Ravizuman NEGATIVE POSITIVE POSITIVE 
26 HP126 TV318 325054 Lakshmi NEGATIVE NEGATIVE NEGATIVE 
27 HP128 TV232 118830 Chellatalini NEGATIVE POSITIVE POSITIVE 
28 HP129 TV311 323478 Selvi NEGATIVE NEGATIVE NEGATIVE 
29 HP130 TV276 104968 Remya POSITIVE POSITIVE POSITIVE 
30 HP131 TV336 432683 Poonkodi NEGATIVE NEGATIVE NEGATIVE 
31 HP133 TV418 534468 Jayasudha NEGATIVE NEGATIVE NEGATIVE 
32 HP134 TV100 200907 Suthasumitra POSITIVE POSITIVE POSITIVE 
33 HP135 TV339 450561 Sumitha NEGATIVE NEGATIVE NEGATIVE 
34 HP136 TV163 310936 Thenmozahi POSITIVE POSITIVE POSITIVE 
35 HP137 TV289 110929 Sumathy NEGATIVE NEGATIVE NEGATIVE 
36 HP138 TV632 300902 Saridha NEGATIVE NEGATIVE NEGATIVE 
37 HP139 TV291 104404 Pushplatha NEGATIVE NEGATIVE NEGATIVE 
38 HP140 TV426 534594 Tamilarsi POSITIVE POSITIVE POSITIVE 
39 HP141 TV275 104968 Sasikala NEGATIVE POSITIVE POSITIVE 
40 HP142 TV346 432704 Vijaylakshmi NEGATIVE NEGATIVE NEGATIVE 
41 HP143 TV315 325114 Manjula NEGATIVE NEGATIVE NEGATIVE 
42 HP144 TV529 373797 Lakshmi NEGATIVE NEGATIVE NEGATIVE 
43 HP145 TV354 474152 Poongavanam POSITIVE POSITIVE POSITIVE 
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44 HP147 TV312 325108 Kokila NEGATIVE NEGATIVE NEGATIVE 
45 HP148 TV499 352322 Poornima POSITIVE POSITIVE POSITIVE 
46 HP149 TV612 481471 Lakshmi NEGATIVE NEGATIVE NEGATIVE 
47 HP150 TV531 461598 Manimeglai NEGATIVE NEGATIVE NEGATIVE 
48 HP151 TV51 324859 Sugna POSITIVE POSITIVE POSITIVE 
49 HP152 TV337 473547 Sudha NEGATIVE NEGATIVE POSITIVE 
50 HP153 TV345 473680 Sythraiselvi NEGATIVE NEGATIVE NEGATIVE 
51 HP155 TV530 102505 Poonkodi NEGATIVE NEGATIVE NEGATIVE 
52 HP156 TV99 200907 Kamatachi POSITIVE POSITIVE POSITIVE 
53 HP157 TV321 333639 Priya NEGATIVE NEGATIVE NEGATIVE 
54 HP158 TV609 482167 Chandra NEGATIVE NEGATIVE NEGATIVE 
55 HP159 TV414 531390 Raleshwari NEGATIVE NEGATIVE NEGATIVE 
56 HP161 TV390 811545 Nirmala NEGATIVE NEGATIVE NEGATIVE 
57 HP163 TV1X 392523 Jamuna POSITIVE POSITIVE POSITIVE 
58 HP164 TV325 324297 Mahasundari NEGATIVE NEGATIVE NEGATIVE 
59 HP165 TV460 599575 Kalaivani POSITIVE POSITIVE POSITIVE 
60 HP166 TV243 640429 Jeyamalini POSITIVE POSITIVE POSITIVE 
61 HP168 TV272 110972 Kalpana NEGATIVE NEGATIVE NEGATIVE 
62 HP169 TV346 432702 Vijaylakshmi NEGATIVE NEGATIVE NEGATIVE 
63 HP171 TV235 650459 Pushpa NEGATIVE NEGATIVE NEGATIVE 
64 HP172 TV646 313492 Deepa NEGATIVE POSITIVE POSITIVE 
65 HP173 TV385 811398 Kalaiselvi POSITIVE POSITIVE POSITIVE 
66 HP174 TV502 352314 Chitra POSITIVE POSITIVE POSITIVE 
67 HP175 TV493 340200 Arputham POSITIVE POSITIVE POSITIVE 
68 HP176 TV252 132531 Akila NEGATIVE NEGATIVE NEGATIVE 
69 HP177 TV305 333432 Devi NEGATIVE NEGATIVE NEGATIVE 
70 HP178 TV541 751338 Venda NEGATIVE POSITIVE POSITIVE 
 
 
Sl.No Code no Sample no Hospital no wet mount Culture PCR 1
1 HP101 TV258 132526 POSITIVE POSITIVE NEGATIVE
2 HP102 TV270 431497 NEGATIVE NEGATIVE POSITIVE
3 HP103 TV267 110668 NEGATIVE NEGATIVE NEGATIVE
4 HP104 TV395 103192 NEGATIVE NEGATIVE NEGATIVE
5 HP105 TV245 191152 NEGATIVE NEGATIVE NEGATIVE
6 HP106 TV181 212504 POSITIVE POSITIVE NEGATIVE
7 HP107 TV304 325662 POSITIVE POSITIVE NEGATIVE
8 HP108 TV650 357315 POSITIVE POSITIVE NEGATIVE
9 HP109 TV333 473677 POSITIVE POSITIVE POSITIVE
10 HP110 TV6 404986 NEGATIVE NEGATIVE NEGATIVE
11 HP111 TV341 461274 NEGATIVE NEGATIVE NEGATIVE
12 HP112 TV335 440078 POSITIVE POSITIVE POSITIVE
13 HP113 TV306 333524 NEGATIVE NEGATIVE NEGATIVE
14 HP114 TV303 325776 POSITIVE POSITIVE POSITIVE
15 HP115 TV302 325444 NEGATIVE NEGATIVE NEGATIVE
16 HP116 TV550 263071 POSITIVE POSITIVE POSITIVE
17 HP117 TV537 16169 NEGATIVE NEGATIVE NEGATIVE
18 HP118 TV450 640704 NEGATIVE POSITIVE NEGATIVE
19 HP119 TV293 132156 POSITIVE POSITIVE NEGATIVE
20 HP120 TV301 325537 NEGATIVE NEGATIVE NEGATIVE
21 HP121 TV281 104570 POSITIVE POSITIVE NEGATIVE
22 HP122 TV278 104950 NEGATIVE NEGATIVE NEGATIVE
23 HP123 TV613 492940 NEGATIVE NEGATIVE NEGATIVE
24 HP124 TV320 324955 NEGATIVE NEGATIVE NEGATIVE
25 HP125 TV183 161282 NEGATIVE POSITIVE POSITIVE
26 HP126 TV318 325054 NEGATIVE NEGATIVE POSITIVE
27 HP128 TV232 118830 NEGATIVE POSITIVE POSITIVE
28 HP129 TV311 323478 NEGATIVE NEGATIVE NEGATIVE
29 HP130 TV276 104968 POSITIVE POSITIVE POSITIVE
30 HP131 TV336 432683 NEGATIVE NEGATIVE NEGATIVE
31 HP133 TV418 534468 NEGATIVE NEGATIVE NEGATIVE
32 HP134 TV100 200907 POSITIVE POSITIVE POSITIVE
33 HP135 TV339 450561 NEGATIVE NEGATIVE NEGATIVE
34 HP136 TV163 310936 POSITIVE POSITIVE NEGATIVE
35 HP137 TV289 110929 NEGATIVE NEGATIVE NEGATIVE
36 HP138 TV632 300902 NEGATIVE NEGATIVE NEGATIVE
37 HP139 TV291 104404 NEGATIVE NEGATIVE NEGATIVE
38 HP140 TV426 534594 POSITIVE POSITIVE NEGATIVE
39 HP141 TV275 104968 POSITIVE POSITIVE NEGATIVE
40 HP142 TV346 432704 NEGATIVE NEGATIVE NEGATIVE
41 HP143 TV315 325114 NEGATIVE NEGATIVE NEGATIVE
42 HP144 TV529 373797 NEGATIVE NEGATIVE NEGATIVE
43 HP145 TV354 474152 POSITIVE POSITIVE POSITIVE
44 HP147 TV312 325108 NEGATIVE NEGATIVE NEGATIVE
45 HP148 TV499 352322 POSITIVE POSITIVE POSITIVE
46 HP149 TV612 481471 NEGATIVE NEGATIVE NEGATIVE
47 HP150 TV531 461598 NEGATIVE NEGATIVE NEGATIVE
MASTER CHART OF CULTURES SAMPLES BLINDED 
(PCR ASSAY DONE WITH CONVENTIONAL METHOD)
48 HP151 TV51 324859 POSITIVE POSITIVE POSITIVE
49 HP152 TV337 473547 NEGATIVE NEGATIVE NEGATIVE
50 HP153 TV345 473680 NEGATIVE NEGATIVE NEGATIVE
51 HP155 TV530 102505 NEGATIVE NEGATIVE NEGATIVE
52 HP156 TV99 200907 POSITIVE POSITIVE POSITIVE
53 HP157 TV321 333639 NEGATIVE NEGATIVE NEGATIVE
54 HP158 TV609 482167 NEGATIVE NEGATIVE NEGATIVE
55 HP159 TV414 531390 NEGATIVE NEGATIVE NEGATIVE
56 HP161 TV390 811545 NEGATIVE NEGATIVE NEGATIVE
57 HP163 TV1X 392523 POSITIVE POSITIVE NEGATIVE
58 HP164 TV325 324297 NEGATIVE NEGATIVE NEGATIVE
59 HP165 TV460 599575 POSITIVE POSITIVE POSITIVE
60 HP166 TV243 640429 POSITIVE POSITIVE POSITIVE
61 HP168 TV272 110972 NEGATIVE NEGATIVE NEGATIVE
62 HP169 TV346 432702 NEGATIVE NEGATIVE NEGATIVE
63 HP171 TV235 650459 NEGATIVE NEGATIVE NEGATIVE
64 HP172 TV646 313492 NEGATIVE POSITIVE NEGATIVE
65 HP173 TV385 811398 POSITIVE POSITIVE NEGATIVE
66 HP174 TV502 352314 POSITIVE POSITIVE NEGATIVE
67 HP175 TV493 340200 POSITIVE POSITIVE NEGATIVE
68 HP176 TV252 132531 NEGATIVE NEGATIVE NEGATIVE
69 HP177 TV305 333432 NEGATIVE NEGATIVE NEGATIVE
70 HP178 TV541 751338 NEGATIVE POSITIVE NEGATIVE
Serial no Code no Sample no Hospital no Wet mount cuculture PCR2
1 HP101 TV258 132526 POSITIVE POSITIVE POSITIVE
2 HP102 TV270 431497 NEGATIVE NEGATIVE NEGATIVE
3 HP103 TV267 110668 NEGATIVE NEGATIVE NEGATIVE
4 HP104 TV395 103192 NEGATIVE NEGATIVE NEGATIVE
5 HP105 TV245 191152 NEGATIVE NEGATIVE NEGATIVE
6 HP106 TV181 212504 POSITIVE POSITIVE POSITIVE
7 HP107 TV304 325662 POSITIVE POSITIVE POSITIVE
8 HP108 TV650 357315 POSITIVE POSITIVE POSITIVE
9 HP109 TV333 473677 POSITIVE POSITIVE POSITIVE
10 HP110 TV6 404986 NEGATIVE NEGATIVE NEGATIVE
11 HP111 TV341 461274 NEGATIVE NEGATIVE NEGATIVE
12 HP112 TV335 440078 POSITIVE POSITIVE POSITIVE
13 HP113 TV306 333524 NEGATIVE NEGATIVE NEGATIVE
14 HP114 TV303 325776 POSITIVE POSITIVE POSITIVE
15 HP115 TV302 325444 NEGATIVE NEGATIVE NEGATIVE
16 HP116 TV550 263071 POSITIVE POSITIVE POSITIVE
17 HP117 TV537 16169 NEGATIVE NEGATIVE NEGATIVE
18 HP118 TV450 640704 NEGATIVE POSITIVE POSITIVE
19 HP119 TV293 132156 POSITIVE POSITIVE NEGATIVE
20 HP120 TV301 325537 NEGATIVE NEGATIVE NEGATIVE
21 HP121 TV281 104570 POSITIVE POSITIVE POSITIVE
22 HP122 TV278 104950 NEGATIVE NEGATIVE NEGATIVE
23 HP123 TV613 492940 NEGATIVE NEGATIVE NEGATIVE
24 HP124 TV320 324955 NEGATIVE NEGATIVE NEGATIVE
25 HP125 TV183 161282 NEGATIVE POSITIVE POSITIVE
26 HP126 TV318 325054 NEGATIVE NEGATIVE NEGATIVE
27 HP128 TV232 118830 NEGATIVE POSITIVE POSITIVE
28 HP129 TV311 323478 NEGATIVE NEGATIVE NEGATIVE
29 HP130 TV276 104968 POSITIVE POSITIVE POSITIVE
30 HP131 TV336 432683 NEGATIVE NEGATIVE NEGATIVE
31 HP133 TV418 534468 NEGATIVE NEGATIVE NEGATIVE
32 HP134 TV100 200907 POSITIVE POSITIVE POSITIVE
33 HP135 TV339 450561 NEGATIVE NEGATIVE NEGATIVE
34 HP136 TV163 310936 POSITIVE POSITIVE POSITIVE
35 HP137 TV289 110929 NEGATIVE NEGATIVE NEGATIVE
36 HP138 TV632 300902 NEGATIVE NEGATIVE NEGATIVE
37 HP139 TV291 104404 NEGATIVE NEGATIVE NEGATIVE
38 HP140 TV426 534594 POSITIVE POSITIVE POSITIVE
39 HP141 TV275 104968 NEGATIVE POSITIVE POSITIVE
40 HP142 TV346 432704 NEGATIVE NEGATIVE NEGATIVE
41 HP143 TV315 325114 NEGATIVE NEGATIVE NEGATIVE
42 HP144 TV529 373797 NEGATIVE NEGATIVE NEGATIVE
43 HP145 TV354 474152 POSITIVE POSITIVE POSITIVE
44 HP147 TV312 325108 NEGATIVE NEGATIVE NEGATIVE
45 HP148 TV499 352322 POSITIVE POSITIVE POSITIVE
46 HP149 TV612 481471 NEGATIVE NEGATIVE NEGATIVE
47 HP150 TV531 461598 NEGATIVE NEGATIVE NEGATIVE
MASTER CHART OF CULTURE BLINDED (PCR
ASSAY DONE USING HOT STAR Taq mix)
48 HP151 TV51 324859 POSITIVE POSITIVE POSITIVE
49 HP152 TV337 473547 NEGATIVE NEGATIVE POSITIVE
50 HP153 TV345 473680 NEGATIVE NEGATIVE NEGATIVE
51 HP155 TV530 102505 NEGATIVE NEGATIVE NEGATIVE
52 HP156 TV99 200907 POSITIVE POSITIVE POSITIVE
53 HP157 TV321 333639 NEGATIVE NEGATIVE NEGATIVE
54 HP158 TV609 482167 NEGATIVE NEGATIVE NEGATIVE
55 HP159 TV414 531390 NEGATIVE NEGATIVE NEGATIVE
56 HP161 TV390 811545 NEGATIVE NEGATIVE NEGATIVE
57 HP163 TV1X 392523 POSITIVE POSITIVE POSITIVE
58 HP164 TV325 324297 NEGATIVE NEGATIVE NEGATIVE
59 HP165 TV460 599575 POSITIVE POSITIVE POSITIVE
60 HP166 TV243 640429 POSITIVE POSITIVE POSITIVE
61 HP168 TV272 110972 NEGATIVE NEGATIVE NEGATIVE
62 HP169 TV346 432702 NEGATIVE NEGATIVE NEGATIVE
63 HP171 TV235 650459 NEGATIVE NEGATIVE NEGATIVE
64 HP172 TV646 313492 NEGATIVE POSITIVE POSITIVE
65 HP173 TV385 811398 POSITIVE POSITIVE POSITIVE
66 HP174 TV502 352314 POSITIVE POSITIVE POSITIVE
67 HP175 TV493 340200 POSITIVE POSITIVE POSITIVE
68 HP176 TV252 132531 NEGATIVE NEGATIVE NEGATIVE
69 HP177 TV305 333432 NEGATIVE NEGATIVE NEGATIVE
70 HP178 TV541 751338 NEGATIVE POSITIVE POSITIVE
Sl.NoTV No. Hosp No. Age Wet Mount Culture PCR Address Sympy/ Asympoccu on Rx HAARTHIV HbsAg HCV Ab VDRL
1 TV1 838385C 33yrs negative negative negative vellore 1 hw 1 1 1 0 1
2 TV2 519964C 25yrs negative negative negative vellore 1 hw 1 1 0 0 0
3 TV3 433489C 25yrs negative negative negative kadapa 1 hw 1 1 1 1 1
4 TV4 837059C 22yrs negative negative negative Thiruvarur 2 hw 1 1 0 0 1
5 TV5 833514C 48yrs negative negative negative vellore 2 hw 1 1 1 1 1
6 TV6 842658c 52yrs negative negative negative W.Bengal 2 hw 1 1 0 0 0
7 TV7 844975C 35yrs negative negative negative jharkhand 2 hw 1 1 0 0 0
8 TV8 812640C 30yrs negative negative negative chittor 1 hw 1 1 0 0 0
9 TV9 839471C 31yrs negative negative negative vellore 1 hw 2 1 0 0 0
10 tv10 852377C 30yrs negative negative negative vellore 2 hw 1 1 1 0 1
12 TV12 816504c 22yrs negative negative negative vellore 1 hw 1 1 0 0 0
13 TV13 210964C 38yrs negative negative negative vellore 1 hw 1 1 0 0 1
14 TV14 32964B 35yrs negative negative negative Kanamang 1 hw 1 1 0 0 0
15 TV15 185743C 36yrs negative negative negative Pochampaly 1 hw 1 1 1 0 1
18 TV18 865439c 31yrs negative negative negative chittor 2 hw 1 1 1 1 1
19 TV19 477546c 36yrs negative negative negative vellore 1 hw 1 1 1 1 0
20 TV20 066498b 29yrs negative negative negative vellore 1 hw 1 1 1 1 1
21 TV21 714471c 49yrs negative negative negative Namakal 1 hw 1 1 0 0 0
22 TV22 862739c 34yrs negative negative negative jharkhand 1 acct 1 1 0 1 2
23 TV23 806080C 34yrs negative negative negative vellore 1 hw 1 1 0 0 0
24 TV24 401173c 30yrs positive positive negative chittor 1 hw 1 1 0 0 0
25 TV25 234502c 25yrs negative negative negative vellore 1 hw 1 1 0 0 0
26 TV26 705186c 33yrs negative negative negative vellore 1 hw 1 1 0 0 0
27 TV27 877008c 52yrs negative negative negative vellore 1 hw 1 1 0 0 1
28 TV28 875767c 52yrs negative negative negative jharkhand 1 hw 1 1 0 0 1
29 TV29 872818c 34yrs negative negative negative krishnagiri 2 hw 1 1 0 0 1
30 TV30 893737c 28yrs negative negative negative jharkhand 2 0 0 0
31 TV31 897306c 27yrs negative negative negative vellore 2 hw 1 1 0 0 0
32 TV32 987228c 24yrs negative negative negative vellore 1 hw 1 1 0 0 1
33 TV33 842117C 39yrs negative negative negative Karanatak 2 hw 1 1 2 1 0
34 TV34 869699c 32yrs negative negative negative vellore 2 hw 1 1 1 1 1
35 TV35 373438c 45yrs negative negative negative vellore 2 hw 1 1 0 0 0
36 TV36 503684c 40yrs negative negative negative chittor 1 hw 2 1 1 1 0
37 TV37 872424c 47yrs negative negative negative chittor 1 labourer 1 1 0 0 1
38 tv38 146742c 30yrs negative negative negative vellore 1 hw 1 1 0 0 1
39 tv39 466371c 39yrs negative negative negative vellore 1 hw 1 1 1 1 0
40 tv40 649355a 29yrs negative negative negative Arcot 1 hw 2 1 0 0 0
41 tv41 908791c 27yrs negative negative negative krishnagiri 2 0 0 0
42 tv42 022611c 49yrs negative negative negative vellore 1 hw 2 1 0 0 0
43 tv43 201481c 31yrs negative negative negative vellore 1 hw 1 1 0 0 0
44 tv44 910616c 34yrs negative negative negative W Bengal 2 hw 1 1 1 1 1
45 tv45 309215c 29yrs negative negative negative Tirupattur 2 hw 1 1 1 0 1
46 TV46 782981b 34yrs negative negative negative vellore 2 hw 1 1 0 0 0
47 tv47 919802c 35yrs negative negative negative cedllore 1 hw 1 1 1 1 0
48 TV48 919974c 37yrs negative negative negative chittor 1 hw 1 1 0 0 0
49 TV49 922019c 36yrs negative negative negative chittor 2 hw 1 1 0 0 1
50 TV50 899317C 27yrs negative negative negative Kadapa 2 hw 1 1 0 0 1
51 TV51 919915c 30yrs negative negative negative jharkhand 2 hw 1 1 0 0 1
52 TV52 234838b 40yrs negative negative negative chittor 1 hw 1 1 1 0 1
53 TV53 911587c 26yrs negative negative negative vellore 1 coolie 1 1 1 1 2
54 TV54 847794c 30yrs negative negative negative vellore 1 hw 1 1 0 0 0
55 TV55 900810c 27yrs negative negative NO SWABchittor
56 TV56 943139c 29yrs negative negative NO SWABvellore
57 TV57 713510c 29yrs negative negative negative Tirupattur 1 hw 2 1 0 0 1
58 TV58 594849c 35yrs negative negative negative vellore 2 hw 1 1 0 0 0 0
59 TV59 964349c 23yrs negative negative negative vellore 2 hw 1 1 0 0 1
60 TV60 691341c 38yrs negative negative negative vellore 2 HW 1 1 0 0 0
61 TV61 963229a 33yrs negative negative negative vellore 1 hw 1 1 1 1 0
63 tv63 728242a 37yrs negative negative negative Gudiyatham 2 hw 1 1 1 0 0
64 TV64 163989C 31yrs negative negative negative Kovai 2 hw 1 1 1 0 1
65 TV65 952587c 48yrs negative negative negative vellore 1 hw 1 1 1 1 2
66 TV66 398540x 24yrs negative negative negative chad 1 hw 1 1 0 0 0
67 TV67 267515x 38yrs negative negative negative chad 1 hw 1 1 0 0 0
69 tv69 972070c 29yrs negative negative negative chittor 1 hw 1 1 1 0 1
70 tv70 405073x 52yrs negative negative negative chad 1 hw 1 1 0 0 0
71 tv71 393074x 32yrs negative negative negative chad 1 hw 1 1 0 0 0
72 tv72 116931x 23yrs negative negative negative chad 1 hw 1 1 0 1 0
73 tv73 415965x 35yrs negative negative positive chad 1 hw 1 1 0 1 0
74 tv74 197684C 32yrs negative negative negative Villupurum 2 hw 1 1 0 0 0
75 TV75 561449a 37yrs negative negative negative vellore 2 hw 1 1 0 0 0
76 tv76 502921c 33yrs negative negative positive A.P 1 hw 2 1 0 1 0
77 tv77 806080C 34yrs negative negative negative vellore 2 coolie 1 1 1 1 1
78 TV78 972680c 41yrs negative negative negative chittor 1 hw 1 1 0 0 0
79 tv79 333331C 26yrs negative negative negative Arcot 1 coolie 1 1 1 0 1
80 TV80 226342c 35yrs negative negative negative vellore 1 hw 1 1 0 1 0
82 tv82 973774c 34yrs negative negative negative jharkhand 2 hw 1 1 0 0 0
83 tv83 349511x 33yrs negative negative negative chad 2 hw 1 1 0 1 0
84 tv84 292639x 28yrs negative negative negative chad 1 hw 1 1 0 1 0
85 tv85 340918x 26yrs negative negative negative vellore 1 hw 1 1 0 1 0
86 tv86 395913x 27yrs negative negative negative chad 1 hw 1 1 0 1 0
87 tv87 977632c 29yrs negative negative negative W.Bengal 1 hw 1 1 0 0 0
88 tv88 929119c 21y negative negative negative chittor 2 hw 1 1 1 1 1
89 tv89 972071c 31yrs negative negative negative vellore 1 hw 1 1 0 0 0
90 tv90 163982c 29yrs negative negative negative vellore 1 hw 2 1 1 1 1
91 tv91 974780C 28yrs negative negative negative chittor 1 hw 1 1 1 1 0
92 TV92 955826B 45y negative negative negative Gudiyatham 1 hw 1 1 0 0 1
93 TV93 242460c 34yrs negative negative negative Cuddapha 1 hw 2 1 0 1 2
94 TV94 979123C 26yrs negative negative negative T.Mali 1 hw 1 1 1 1 1
95 TV95 427555c 32yrs negative negative negative Kadapa 1 hw 1 1 1 1 1
193 TV193 13226D 27yrs negative negative negative Thhirupattur 1 hw 1 1 1 1 0
194 TV194 130341D 39yrs negative negative negative vellore 2 hw 1 1 1 1 2
195 TV195 381888X 23yrs negative negative negative chad 1 hw 1 1 0 0 0
196 TV196 390539X 37yrs negative negative negative chad 1 hw 1 1 0 0 0
197 TV197 138151D 35yrs negative negative negative vellore 1 hw 1 1 0 0 1
198 TV198 123459D 36yrs negative negative negative vellore 1 hw 1 1 1 1 1
199 TV199 096479D 23yrs negative negative negative krishnagiri 2 hw 1 1 1 0 1
200 TV200 123019D 33yrs negative positive positive vellore 2 hw 1 1 1 1 1
201 TV201 137097D 27yrs negative negative negative krishnagiri 1 1 0 0 1
202 TV202 675139C 22yrs negative negative negative vellore 1 hw 1 1 1 0 1
203 TV203 379175X 25yrs negative negative negative chad 2 hw 1 1 0 0 0
204 TV204 366360X 25yrs negative positive positive chad 1 hw 1 1 0 0 0
205 TV205 355419X 36yrs negative negative negative chad 1 hw 1 1 0 0 0
206 TV206 407743X 38yrs negative negative negative chad 1 hw 1 1 0 1 0
207 TV207 412225X 28yrs negative negative negative chad 1 hw 1 1 0 1 0
208 TV208 380998X 27yrs negative negative negative chad 2 hw 1 1 0 1 0
209 TV209 971794C 23yrs negative negative negative vellore 2 hw 1 1 0 0 1
210 TV210 827618C 27yrs negative negative negative W.Bengal 1 hw 1 1 1 1 1
211 TV211 395913X 27yrs negative negative negative chad 1 hw 1 0 1 0
212 TV212 410113X 26yrs negative negative negative chad 1 hw 1 1 0 1 0
213 TV213 272525X 32yrs negative negative negative chad 1 hw 1 1 0 1 0
214 TV214 167952D 27yrs negative negative positive vellore 1 hw 1 1 1 0 2
215 TV215 173850B 30yrs negative negative negative chittor 1 hw 1 1 0 0 0
216 TV216 430546X 39yrs negative negative negative chad 2 hw 1 1 0 1 0
217 TV217 214893X 32yrs negative negative negative chad 2 hw 1 1 0 0 0
218 TV218 176358D 30yrs negative negative negative kadapa 1 teacher 1 1 1 1 1
219 TV219 165801D 36yrs negative negative negative Cuddapha 1 hw 1 1 1 1 1
220 TV220 148799D 35yrs negative negative negative Chittor 1 hw 1 1 1 1 1
221 TV221 276955X 33yrs negative negative negative chad 1 hw 1 1 0 0 0
222 TV222 671767C 38yrs negative negative negative Chittor 1 hw 1 1 1 1 1
223 TV223 180923D 50yrs negative negative negative t.v mali 1 labourer 1 1 1 1 1
224 TV224 346514X 25yrs negative negative negative chad 2 hw 1 1 0 1 0
225 TV225 116931X 23yrs negative negative negative chad 1 hw 1 1 0 1 0
226 TV226 194360C 30yrs negative CULTUREMEDIA SPvellore
227 TV227 185248D 32yrs negative CULTUREMEDIA SPvellore
228 TV228 332759X  38yrs negative negative negative chhad 1 hw 1 1 0 1 0
229 TV229 426122X 31yrs negative negative negative Chittor 1 hw 1 1 0 1 0
230 TV230 896338B 33yrs negative negative positive vellore 1 hw 1 1 0 0 1
231 TV231 113983D 36yrs negative negative negative krishnagiri 2 hw 1 1 1 1 1
232 TV232 118830D 48yrs negative positive positive Erode 1 labourer 1 1 1 1 1
233 TV233 183618D 38yrs negative negative negative vellore 1 hw 1 1 1 1 1
234 TV234 037608D 24yrs negative negative negative jharkhand 1 service 1 1 0 0 0
235 TV235 984485C 38yrs negative negative negative vellore 2 hw 2 1 1 1 1
236 TV236 207188D 25yrs negative negative negative Arrakonam 1 hw 1 1 1 1 0
237 TV237 218478D 30yrs negative negative negative W.Bengal 1 hw 1 1 1 1 1
238 TV238 201209B 38yrs negative negative negative Chittor 1 hw 1 1 1 1 0
239 TV239 184135D 31yrs negative negative negative vellore 1 hw 1 1 1 1 1
240 TV240 147161C 40yrs negative negative negative vellore 1 hw 2 1 0 0 0
241 TV241 197809D 46yrs negative negative negative banglore 1 hw 1 1 1 1 1
242 TV242 175606D 28yrs negative negative negative vellore 1 hw 1 1 1 1 1
243 TV243 042930D 27yrs negative negative negative Arcot 2 hw 1 1 1 1 1
244 TV244 791462C 29yrs negative negative negative vellore 1 hw 1 1 1 0 1
245 TV245 219429D 22yrs negative negative negative krishnagiri 2 hw 1 1 1 1 1
246 TV246 025607C 26yrs negative negative negative Cheriyar 1 hw 1 1 1 0 1
247 TV247 963229A 33yrs negative negative negative vellore 1 hw 1 1 1 1 1
248 TV248 206152D 33yrs negative negative negative west beng 2 hw 1 1 1 1 1
249 TV249 199433D 31yrs negative negative negative chittor 2 hw 1 1 1 0 1
250 TV250 230924D 50yrs negative negative negative Tanjore 1 hw 1 1 1 1 1
251 TV251 842264C 51y negative negative negative vellore 2 hw 1 1 1 1 1
252 TV252 005441D 32yrs negative negative negative W.Bengal 2 hw 1 1 1 1 1
253 TV253 109891D 46yrs negative negative negative chittor 1 hw 2 1 1 1 1
254 TV254 054988D 30yrs negative negative negative vellore 1 hw 1 1 1 1 1
255 TV255 235476D 27yrs negative negative negative vellore 1 hw 1 1 1 1 1
256 TV256 609510C 38yrs negative negative negative vellore 1 hw 1 1 0 1 0
257 TV257 225038C 28yrs negative negative negative vellore 1 hw 1 1 0 0 0
258 TV258 234973D 25yrs negative positive positive Apradesh 1 hw 1 1 1 1 1
259 TV259 235155D 36yrs negative negative negative Pondi 1 hw 1 1 1 0 0
260 TV260 239479D 44y negative negative negative vellore 1 hw 1 1 1 2 1
261 TV261 234128D 36yrs negative negative negative Trichy 1 hw 1 1 1 1 1
262 TV262 121508C 36yrs negative negative negative vellore 1 hw 1 1 1 1 1
263 TV263 234002D 35yrs negative negative positive W.Bengal 1 hw 1 1 1 1 1
264 TV264 225152D 36yrs negative negative negative vellore 1 hw 1 1 1 1 1
265 TV265 800576D 39yrs negative negative negative vellore 2 hw 1 1 0 0 0
266 TV266 171143D 36yrs negative negative negative T.Mali 1 hw 1 1 1 0 1
267 TV267 941641D 34yrs negative negative negative wBengal 1 hw 1 1 0 0 0
268 TV268 837931C 32yrs negative negative negative vellore 1 hw 1 1 1 1 1
269 TV269 243839D 21y negative negative negative Villupurum 1 coolie 1 1 1 1 1
270 TV270 246815D 47yrs negative negative negative A.P 1 hw 1 1 1 1 1
271 TV271 248593D 28yrs negative negative negative vellore 1 hw 1 1 1 1 1
272 TV272 809616C 36yrs negative negative negative vellore 1 hw 1 1 1 1 1
273 TV273 248593D 36yrs negative negative negative vellore 1 hw 1 1 1 1 1
274 TV274 246668D 36yrs negative negative negative A.P 1 hw 1 1 1 1 1
275 TV275 159625D 36yrs negative negative negative krishnagiri 1 hw 1 1 1 1 1
276 TV276 992888C 28yrs negative negative negative vellore 2 hw 1 1 1 0 1
277 TV277 252357D 46yrs negative negative negative krishnagiri 1 farmer 1 1 1 1 1
278 TV278 248548D 45yrs negative negative negative kadapa 1 hw 1 1 1 1 2
279 TV279 254014D 36yrs negative negative negative wBengal 1 hw 1 1 1 1 1
280 TV280 187575C 45yrs negative negative negative vellore 1 hw 1 1 1 1 1
281 TV281 913971C 52yrs negative negative negative Chittor 1 hw 1 1 1 1 1
282 TV282 633679C 32yrs negative negative negative krishnagiri 1 hw 1 1 1 1 0
283 TV283 255861D 25yrs negative negative negative t.v mali 1 hw 1 1 0 0 0
284 TV284 168771C 26yrs negative negative negative Chittor 1 hw 1 1 1 0 1
285 TV285 283910C 30yrs negative negative negative Chittor 1 labourer 1 1 0 0 0
286 TV286 114496D 28yrs negative positive positive vellore 2 hw 1 1 1 1 1
287 TV287 260190D 50yrs negative negative negative chittor 1 hw 1 1 1 1 1
288 TV288 058837D 39yrs negative negative negative vellore 1 hw 1 1 1 1 1
289 TV289 866807C 22yrs negative negative negative vellore 1 hw 1 1 1 1 1
290 TV290 042254D 37yrs negative negative negative Erode 2 labourer 1 1 1 1 0
291 tv291 802700c 41yrs negative negative negative Chittor 1 hw 1 1 1 1 1
292 TV292 206090D 32yrs negative negative negative Kanchiuram 1 hw 1 1 1 1 1
293 tv293 096479D 23yrs negative negative negative krishnagiri 2 hw 1 1 1 0 1
294 tv294 885619D 36yrs negative negative negative Salem 1 hw 1 1 0 0 0
295 tv295 265239D 38yrs negative negative negative Chittor 1 hw 1 1 1 1 1
296 TV296 264943c 28yrs negative negative negative vellore 1 labourer 1 1 1 1 1
297 TV 297736882c 32yrs negative negative negative vellore 1 labourer 1 1 1 1 1
298 tv298 264943c 28yrs negative negative negative vellore 1 hw 1 1 0 0 0
299 tv299 266974D 26yrs negative negative negative Vellore 1 Chital 1 1 0 1 1
300 TV300 984485C 38yrs negative negative negative vellore 2 hw 1 1 1 1 1 1
301 TV301 149948D 40yrs negative negative negative jharkhand 1 hw 1 1 1 1 1
302 tv302 268623D 26yrs negative negative negative CHITTOR 1 HW 1 1 1 0 1
303 TV303 271338D 27yrs negative negative negative Madurai 2 HW 1 1 1 1 1
304 TV304 002975D 37yrs negative negative negative vellore 1 hw 1 1 1 1 1
305 TV305 978195c 35yrs negative negative negative vellore 2 labourer 1 1 0 0 1
306 tv306 267087D 30yrs negative negative positive Krishnagiri 2 HW 0 1 1 1 1 1
307 TV307 186988D 33yrs negative negative negative vellore 1 coolie 1 1 1 1 1
